Document:

<PAGE>

                                                                   EXHIBIT 10.16

                                   M-WISE INC.

                           INVESTORS' RIGHTS AGREEMENT

                                January 11, 2001

<PAGE>

                                TABLE OF CONTENTS

                                                                           Page
                                                                           ----

1. Registration Rights.......................................................1
   1.1      Definitions......................................................2
   1.2      Request for Registration.........................................3
   1.3      Company Registration.............................................4
   1.4      Form S-3 Registration............................................5
   1.5      Obligations of the Company.......................................6
   1.6      Furnish Information..............................................7
   1.7      Expenses of Registration.........................................7
   1.8      Underwriting Requirements........................................8
   1.9      Delay of Registration............................................9
   1.10     Indemnification..................................................9
   1.11     Reports Under Securities Exchange Act of 1934...................11
   1.12     Foreign Registration............................................11
   1.13     Limitations on Subsequent Registration Rights...................12
   1.14     "Market Stand-Off" Agreement....................................12
   1.15     Termination of Registration Rights..............................13

2. Covenants of the Company.................................................13
   2.1      Delivery of Financial Statements................................13
   2.2      Inspection......................................................14
   2.3      Right of First Refusal..........................................14
   2.4      Key Person Life Insurance.......................................15
   2.5      Proprietary Information and Inventions Agreements...............16
   2.6      Publication.....................................................16
   2.7      Termination of Covenants........................................16

3. Miscellaneous............................................................16
   3.1      Successors and Assigns..........................................16
   3.2      Amendments and Waivers..........................................16
   3.3      Notices.........................................................16
   3.4      Effect of Change in Company's Capital Structure.................17
   3.5      Attorney Fees...................................................17
   3.6      Severability....................................................17
   3.7      Governing Law...................................................17
   3.8      Counterparts....................................................17
   3.9      Titles and Subtitles............................................17
   3.10     Aggregation of Stock............................................17
   3.11     Specific Enforcement............................................17
   3.12     Entire Agreement; Superseding Effect............................17

                                        i

<PAGE>

                           INVESTORS' RIGHTS AGREEMENT

                  This Investors' Rights Agreement (the "Agreement") is made as
of the 11th day of January, 2001, by and among m-Wise, Inc., a Delaware
corporation (the "Company") and the investors listed on Exhibit A hereto (or any
subsidiary thereof, any entity into which any such investor shall merge or any
subsidiary of such entity), each of which is herein referred to as an
"Investor."

                                    RECITALS

                  WHEREAS, certain of the Investors possess registration rights,
information rights and rights of first refusal pursuant to a Subscription
Agreement dated as of April 12, 2000, as amended, among the Company and such
Investors (the "Subscription Agreement") and as set forth in the Company's
Certificate of Designation, Preferences and Rights of the Series A Preferred A
Stock, par value $0.01 per share (the "Series A Preferred Stock"), of the
Company;

                  WHEREAS, pursuant to a waiver and termination agreement dated
as of the date hereof (the "Waiver"), such Investors have agreed, among other
things, to terminate their rights under the Subscription Agreement and as set
forth in the Certificate of Designation, Preferences and Rights of the Series A
Preferred Stock, and to accept the rights created pursuant hereto in lieu
thereof;

                  WHEREAS, the Company and certain other Investors have entered
into a purchase agreement (the "Purchase Agreement") of even date herewith
pursuant to which the Company desires to sell to such Investors and such
Investors desire to purchase from the Company shares of Series B Preferred
Stock, par value $0.01 per share (the "Series B Preferred Stock" and, together
with the Series A Preferred Stock, the "Preferred Stock"), of the Company and
warrants to purchase shares of Series B Preferred Stock;

                  WHEREAS, a condition to those Investors' obligations under the
Purchase Agreement is that the Company and the Investors enter into this
Agreement in order to provide the Investors with (i) certain rights to register
shares of the Company's Common Stock or issuable upon conversion of the
Preferred Stock held by the Investors, (ii) certain rights to receive or inspect
information pertaining to the Company, and (iii) a right of first offer with
respect to certain issuances by the Company of its securities; and

                  WHEREAS, the Company desires to induce certain of the
Investors to purchase shares of Series B Preferred Stock and warrants for shares
of Series B Preferred Stock pursuant to the Purchase Agreement by agreeing to
the terms and conditions set forth herein.

                  NOW, THEREFORE, in consideration of the mutual promises,
representations, warranties, covenants and conditions set forth in this
Agreement and in the Purchase Agreement, the parties hereto agree as follows:

         1. Registration Rights. The Company and the Investors covenant and
agree as follows:

<PAGE>

         1.1 Definitions. For purposes of this Section 1:

         (a) The term "Form S-3" means such form under the Securities Act as in
effect on the date hereof or any successor form under the Securities Act;

         (b) The term "Holder" means any Series A Holder or Series B Holder;

         (c) The term "Qualified IPO" means a firm commitment underwritten
public offering by the Company of shares of its Common Stock pursuant to a
registration statement filed in the United States under the Securities Act or a
public offering effected on the London Stock Exchange, the Frankfurt Stock
Exchange or the Paris Stock Exchange under applicable securities laws, with a
pre-money valuation in excess of $60,000,000 and which results in aggregate cash
proceeds to the Company of an amount equal to or greater than $20,000,000, net
of underwriting discounts and commissions.

         (d) The terms "register," "registered," and "registration" refer to a
registration effected by preparing and filing a registration statement or
similar document in compliance with the Securities Act of 1933, as amended (the
"Securities Act"), and the declaration or ordering of effectiveness of such
registration statement or document;

         (e) The term "Registrable Securities" means (i) the shares of Common
Stock issuable or issued upon conversion of the Preferred Stock (including the
Preferred Stock issued upon exercise of the Warrants) and (ii) any other shares
of Common Stock of the Company issued as (or issuable upon the conversion or
exercise of any warrant, right or other security which is issued as) a dividend
or other distribution with respect to, or in exchange for or in replacement of,
the securities listed in (i); provided, however, that the foregoing definition
shall exclude in all cases any Registrable Securities sold by a person in a
transaction in which his, her or its rights under this Agreement are not
assigned. Notwithstanding the foregoing, Common Stock or other securities shall
only be treated as Registrable Securities if and so long as they have not been
(A) sold to or through a broker or dealer or underwriter in a public
distribution or a public securities transaction, or (B) sold in a transaction
exempt from the registration and prospectus delivery requirements of the
Securities Act under Section 4(l) thereof so that all transfer restrictions, and
restrictive legends with respect thereto, if any, are removed upon the
consummation of such sale;

         (f) The number of shares of "Registrable Securities then outstanding"
shall be determined by the number of shares of Common Stock outstanding which
are Registrable Securities, and the number of shares of Common Stock which are
Registrable Securities and which are issuable pursuant to then exercisable or
convertible securities;

         (g) The term "SEC" means the Securities and Exchange Commission;

         (h) The term "Series A Holder" means any person owning Registrable
Securities that are shares of Common Stock issuable or issued upon conversion of
the Series A Preferred Stock (including the Series A Preferred Stock issued upon
exercise of the warrant for 56,180 shares of Series A Preferred Stock) and any
other shares of Common Stock of the Company issued as (or issuable upon the
conversion or exercise of any warrant, right or other security which is issued
as) a dividend or other distribution with respect to, or in exchange for or in
replacement of, such securities, or any assignee thereof

                                       2
<PAGE>

         (i) The term "Series B Holder" means any person owning Registrable
Securities that are shares of Common Stock issuable or issued upon conversion of
the Series B Preferred Stock (including the Series B Preferred Stock issued upon
exercise of the warrants for shares of Series B Preferred Stock purchased
pursuant to the Purchase Agreement) and any other shares of Common Stock of the
Company issued as (or issuable upon the conversion or exercise of any warrant,
right or other security which is issued as) a dividend or other distribution
with respect to, or in exchange for or in replacement of, such securities, or
any assignee thereof; and

         (j) The term "Warrants" means (i) the warrant dated April 26, 2000 for
56,180 shares of Series A Preferred Stock or (ii) the warrants for shares of the
Company's Series B Preferred Stock purchased by certain of the Investors
pursuant to the Purchase Agreement;

         1.2 Request for Registration.

         (a) If the Company shall receive at any time after six (6) months after
the effective date of the first registration statement for a public offering of
securities of the Company (other than a registration statement relating either
to the sale of securities to employees of the Company pursuant to a stock
option, stock purchase or similar plan approved by the Board of Directors of the
Company or an SEC Rule 145 transaction approved by the Board of Directors of the
Company), a written request from (x) e-street international ag or any affiliate
thereof ("e-street") or D.E.P. Technology Holdings Ltd or any affiliate thereof
("DEP") or (y) the Holders of at least 50% of the Series A Preferred Stock (or
any other Registrable Securities issued or issuable in respect of such shares or
in exchange therefor) then outstanding that the Company file a registration
statement under the Securities Act covering the registration of a number of the
Registrable Securities then outstanding with an anticipated aggregate gross
offering price of at least $4,000,000, then the Company shall, within ten (10)
days of the receipt thereof, give written notice of such request to all Holders
and shall, subject to the limitations of subsection 1.2(b), file a registration
statement covering such Registrable Securities within 60 days of the receipt of
such request and use its best efforts to effect as soon as practicable the
registration under the Securities Act of all Registrable Securities which the
Holders request to be registered within fifteen (15) days of the mailing of such
notice by the Company in accordance with Section 3.3.

         (b) If the Holders initiating the registration request hereunder
("Initiating Holders") intend to distribute the Registrable Securities covered
by their request by means of an underwriting, they shall so advise the Company
as a part of their request made pursuant to this Section 1.2 and the Company
shall include such information in the written notice referred to in subsection
1.2(a). The underwriter will be selected by a majority in interest of the
Initiating Holders and shall be reasonably acceptable to the Company. In such
event, the right of any Holder to include his Registrable Securities in such
registration shall be conditioned upon such Holder's participation in such
underwriting and the inclusion of such Holder's Registrable Securities in the
underwriting (unless otherwise mutually agreed by a majority in interest of the
Initiating Holders and such Holder) to the extent provided herein. All Holders

                                       3
<PAGE>

proposing to distribute their securities through such underwriting shall
(together with the Company as provided in subsection 1.5(e)) enter into an
underwriting agreement in customary form with the underwriter or underwriters
selected for such underwriting. Notwithstanding any other provision of this
Section 1.2, if the underwriter advises the Initiating Holders in writing that
marketing factors require a limitation of the number of shares to be
underwritten, then the Initiating Holders shall so advise all Holders of
Registrable Securities which would otherwise be underwritten pursuant hereto,
and the number of shares of Registrable Securities that may be included in the
underwriting shall be allocated (x) if the Initiating Holders are e-street or
DEP, first, among the Initiating Holders, second, among the Series B Holders,
and third, among the Series A Holders, and (y) if the Initiating Holders are any
other Holders, pro rata among the Holders, and in each case, in proportion (as
nearly as practicable) to the amount of Registrable Securities of the Company
owned by each such Holder; provided, however, that the number of shares of
Registrable Securities to be included in such underwriting shall not be reduced
unless all other securities, if any, are first entirely excluded from the
underwriting.

         (c) Notwithstanding the foregoing, if the Company shall furnish to
Holders requesting a registration statement pursuant to this Section 1.2, a
certificate signed by the Chief Executive Officer of the Company stating that in
the good faith judgment of the Board of Directors of the Company, it would be
seriously detrimental to the Company and its stockholders for such registration
statement to be filed and it is therefore essential to defer the filing of such
registration statement, the Company shall have the right to defer such filing
for a period of not more than 90 days after receipt of the request of the
Initiating Holders; provided, however, that the Company may not utilize this
right more than once in any twelve-month period.

         (d) In addition, the Company shall not be obligated to effect, or to
take any action to effect, any registration pursuant to this Section 1.2:

         (i) Subject to the forfeiture provision in Section 1.7(a), after the
Company has effected (x) one (1) registration initiated by e-street, (y) one (1)
registration initiated by DEP and (z) one (1) registration initiated by the
Series A Holders, and each such registration has been declared or ordered
effective;

         (ii) During the one hundred eighty (180) days after the effective date
of a registration subject to Section 1.3; or

         (iii) If the Initiating Holders propose to dispose of shares of
Registrable Securities that may be immediately registered on Form S-3 pursuant
to a request made pursuant to Section 1.4 below.

         1.3 Company Registration. If (but without any obligation to do so) the
Company proposes to register (including for this purpose a registration effected
by the Company for stockholders other than the Holders) any of its stock under
the Securities Act in connection with the public offering of such securities
solely for cash (other than a registration relating solely to the sale of
securities to participants in a Company stock plan approved by the Board of
Directors of the Company or a transaction covered by Rule 145 under the
Securities Act approved by the Board of Directors of the Company, a registration
in which the only stock being registered is Common Stock issuable upon
conversion of debt securities which are also being registered, or any

                                       4
<PAGE>

registration on any form which does not include substantially the same
information as would be required to be included in a registration statement
covering the sale of the Registrable Securities), the Company shall, at such
time, promptly give each Holder and all other holders of Common Stock of the
Company (including shares of Common Stock issued or issuable upon conversion of
shares of any currently unissued series of preferred stock of the Company) with
registration rights ("Other Shares") written notice of such registration. Upon
the written request of each Holder of Registrable Securities or holder of Other
Shares given within fifteen (15) days after mailing of such notice by the
Company in accordance with Section 3.3, the Company shall, subject to the
provisions of Section 1.8, use its best efforts to cause to be registered under
the Securities Act all of the Registrable Securities that each such Holder has
requested to be registered. If a Holder decides not to include any or all of its
Registrable Securities in any registration statement filed by the Company, such
Holder shall nevertheless continue to have the right to include any Registrable
Securities in any subsequent registration statement or statements as may be
filed by the Company with respect to offerings of its securities, all upon the
terms and conditions set forth herein.

         1.4 Form S-3 Registration. In case the Company shall receive from any
Holder or Holders a written request or requests that the Company effect a
registration on Form S-3, and any related qualification or compliance with
respect to all or a part of the Registrable Securities owned by such Holder or
Holders, the anticipated aggregate gross offering price to the public of which
would not be less than $1,000,000, the Company will:

         (a) promptly give written notice of the proposed registration, and any,
related qualification or compliance, to all other Holders; and

         (b) as soon as practicable, use its best efforts to effect such
registration, up to two (2) per year, and all such qualifications and
compliances as may be so requested and as would permit or facilitate the sale
and distribution of all or such portion of such Holder's or Holders' Registrable
Securities as are specified in such request, together with all or such portion
of the Registrable Securities of any other Holder or Holders joining in such
request as are specified in a written request given within twenty (20) days
after receipt of such written notice from the Company; provided, however, that
the Company shall not be obligated to effect any such registration,
qualification or compliance, pursuant to this Section 1.4: (i) if Form S-3 is
not available for such offering by the Holders; (ii) if the Holders, together
with the holders of any other securities of the Company entitled to inclusion in
such registration, propose to sell Registrable Securities and such other
securities (if any) at an aggregate gross price to the public of less than
$1,000,000; (iii) if the Company shall furnish to the Holders a certificate
signed by the Chief Executive Officer of the Company stating that in the good
faith judgment of the Board of Directors of the Company, it would be seriously
detrimental to the Company and its stockholders for such Form S-3 Registration
to be effected at such time, in which event the Company shall have the right to
defer the filing of the Form S-3 registration statement for a period of not more
than 90 days after receipt of the request of the Holder or Holders under this
Section 1.4; provided, however, that the Company shall not utilize this right
more than once in any twelve month period; (iv) if the Company has, within the
twelve (12) month period preceding the date of such request, already effected
two registrations on Form S-3 for the Holders pursuant to this Section 1.4; or
(v) during the one hundred eighty (180) days after the effective date of a
registration statement subject to Section 1.3.

                                       5
<PAGE>

         (c) Subject to the foregoing, the Company shall file a registration
statement covering the Registrable Securities as soon as practicable after
receipt of the request or requests of the Holders. Registrations effected
pursuant to this Section 1.4 shall not be counted as demands for registration or
registrations effected pursuant to Section 1.2.

         1.5 Obligations of the Company. Whenever required under this Section 1
to effect the registration of any Registrable Securities, the Company shall, as
expeditiously as reasonably possible:

         (a) Prepare and file with the SEC a registration statement with respect
to such Registrable Securities and use its best efforts to cause such
registration statement to become effective, and, upon the request of the Holders
of a majority of the Registrable Securities registered thereunder, keep such
registration statement effective for up to one hundred eighty (180) days.

         (b) Prepare and file with the SEC such amendments and supplements to
such registration statement and the prospectus used in connection with such
registration statement as may be necessary to comply with the provisions of the
Securities Act with respect to the disposition of all securities covered by such
registration statement for up to one hundred eighty (180) days.

         (c) Furnish to the Holders such numbers of copies of a prospectus,
including a preliminary prospectus, in conformity with the requirements of the
Securities Act, and such other documents as they may reasonably request in order
to facilitate the disposition of Registrable Securities owned by them.

         (d) Use its best efforts to register and qualify the securities covered
by such registration statement under such other securities or Blue Sky laws of
such jurisdictions as shall be reasonably requested by the Holders, provided
that the Company shall not be required in connection therewith or as a condition
thereto to qualify to do business or to file a general consent to service of
process in any such states or jurisdictions in which the Company is not already
qualified to do business or subject to service of process.

         (e) In the event of any underwritten public offering, enter into and
perform its obligations under an underwriting agreement, in usual and customary
form, with the managing underwriter of such offering. Each Holder participating
in such underwriting shall also enter into and perform its obligations under
such an agreement.

         (f) Notify each Holder of Registrable Securities covered by such
registration statement at any time when a prospectus relating thereto is
required to be delivered under the Securities Act of the happening of any event
as a result of which the prospectus included in such registration statement, as
then in effect, includes an untrue statement of a material fact or omits to
state a material fact required to be stated therein or necessary to make the
statements therein not misleading in the light of the circumstances then
existing.

         (g) Cause all such Registrable Securities registered pursuant hereunder
to be listed on each securities exchange or over-the-counter market on which
similar securities issued by the Company are then listed.

                                       6
<PAGE>

         (h) Provide a transfer agent and registrar for all Registrable
Securities registered pursuant hereunder and a CUSIP number for all such
Registrable Securities, in each case not later than the effective date of such
registration.

         (i) Use its best efforts to furnish, at the request of any Holder
requesting registration of Registrable Securities pursuant to this Section 1, on
the date that such Registrable Securities are delivered to the underwriters for
sale in connection with a registration pursuant to this Section 1, if such
securities are being sold through underwriters, or, if such securities are not
being sold through underwriters, on the date that the registration statement
with respect to such securities becomes effective, (i) an opinion, dated such
date, of the counsel representing the Company for the purposes of such
registration, in form and substance as is customarily given to underwriters in
an underwritten public offering, addressed to the underwriters, if any, and to
the Holders requesting registration of Registrable Securities and (ii) a letter
dated such date, from the independent certified public accountants of the
Company, in form and substance as is customarily given by independent certified
public accountants to underwriters in an underwritten public offering, addressed
to the underwriters, if any, and to the Holders requesting registration of
Registrable Securities.

         1.6 Furnish Information. It shall be a condition precedent to the
obligations of the Company to take any action pursuant to this Section 1 with
respect to the Registrable Securities of any selling Holder that such Holder
shall furnish to the Company such information regarding itself, the Registrable
Securities held by it, and the intended method of disposition of such securities
as shall be required to effect the registration of such Holder's Registrable
Securities. The Company shall have no obligation with respect to any
registration requested pursuant to Section 1.2 or Section 1.4 of this Agreement
if, as a result of the application of the preceding sentence, the number of
shares or the anticipated aggregate offering price of the Registrable Securities
to be included in the registration does not equal or exceed the number of shares
or the anticipated aggregate offering price required to originally trigger the
Company's obligation to initiate such registration as specified in subsection
1.2(a) or section 1.4, whichever is applicable.

         1.7 Expenses of Registration.

         (a) Demand Registration. All expenses (other than underwriting
discounts and commissions, which shall be borne by participating Holders in
proportion to the number of Registrable Securities to be registered) incurred in
connection with registrations, filings or qualifications pursuant to Section
1.2, including (without limitation) all registration, filing and qualification
fees, printers' and accounting fees, fees and disbursements of counsel for the
Company, and the reasonable fees and disbursements of one counsel for the
selling Holders selected by them, shall be borne by the Company; provided,
however, that the Company shall not be required to pay for any expenses of any
registration proceeding begun pursuant to Section 1.2 if the registration
request is subsequently withdrawn at the request of the Initiating Holders and
the Company is in compliance with this Agreement (in which case all Initiating
Holders shall bear all such reasonable expenses in proportion to the number of
shares for which registration was requested), unless the Initiating Holders
agree to forfeit their right to one demand registration pursuant to Section 1.2;
provided further, however, that if at the time of such withdrawal, the
Initiating Holders have learned of a material adverse change in the condition,

                                       7
<PAGE>

results, business, or prospects of the Company from that known to the Initiating
Holders at the time of their request and have withdrawn the request with
reasonable promptness following disclosure by the Company of such material
adverse change, then the Holders shall not be required to pay any of such
expenses and shall retain their rights pursuant to Section 1.2.

         (b) Company Registration. All expenses other than underwriting
discounts and commissions incurred in connection with registrations, filings or
qualifications of Registrable Securities pursuant to Section 1.3 for each
Holder, including (without limitation) all registration, filing, and
qualification fees, printers' and accounting fees, fees and disbursements of
counsel for the Company and the reasonable fees and disbursements of one counsel
for the selling Holder or Holders selected by them shall be borne by the
Company.

         (c) Registration on Form S-3. All expenses other than underwriters'
discounts or commissions incurred in connection with registrations requested
pursuant to Section 1.4, including (without limitation) all registration,
filing, qualification, printers' and accounting fees and the reasonable fees and
disbursements of one counsel for the selling Holder or Holders selected by them
and counsel for the Company, associated with Registrable Securities, shall be
borne by the Company.

         1.8 Underwriting Requirements. In connection with any offering
involving an underwriting of shares of the Company's capital stock, the Company
shall not be required under Section 1.3 to include any of the Registrable
Securities or Other Shares in such underwriting unless the holders thereof
accept the usual and customary terms of the underwriting as agreed upon between
the Company and the underwriters selected by the Holders (or by other persons
entitled to select the underwriters) and reasonably agreed to by the Company,
and then only in such quantity as the underwriters determine in their sole
discretion will not jeopardize the success of the offering by the Company. If
the total amount of Registrable Securities and Other Shares requested by
stockholders to be included in such offering exceeds the amount of securities to
be sold, other than by the Company, that the underwriters determine in their
sole discretion is compatible with the success of the offering, then the Company
shall be required to include in the offering only that number of such
securities, including Registrable Securities, which the underwriters determine
in their sole discretion will not jeopardize the success of the offering, the
securities so included to be apportioned as follows: (i) the securities of the
Company held by officers and directors of the Company (including Registrable
Shares) and by holders of Other Shares shall be excluded from such registration
and underwriting to the extent deemed advisable by the managing underwriter, and
(ii) if a further limitation on the number of shares is required after all
securities held by officers and directors of the Company and all Other Shares
have been excluded, the number of shares that may be included in such
registration and underwriting shall be allocated among all Holders requesting
registration in proportion, as nearly as practicable, to the respective number
of Registrable Securities owned by each such Holder; provided that, except in
the case of the initial public offering of the Company, when all Registrable
Shares may be excluded if the underwriters make the determination described
above and no other stockholder's securities are included, the number of
Registrable Shares permitted to be included therein shall in any event be at
least 33% of the total amount of securities included therein and shall be
allocated among the Holders pro rata based on the number of Registrable
Securities each such Holder has requested to be included in such offering.

                                       8
<PAGE>

         1.9 Delay of Registration. No Holder shall have any right to obtain or
seek an injunction restraining or otherwise delaying any such registration as
the result of any controversy that might arise with respect to the
interpretation or implementation of this Section 1.

         1.10 Indemnification. In the event any Registrable Securities are
included in a registration statement under this Section 1:

         (a) To the extent permitted by law, the Company will indemnify and hold
harmless each Holder, each of its officers, directors and partners, legal
counsel and accountants, any underwriter (as defined in the Securities Act) for
such Holder and each person, if any, who controls such Holder or underwriter
within the meaning of the Securities Act or the Securities Exchange Act of 1934,
as amended (the "Exchange Act"), against any losses, claims, damages, or
liabilities (joint or several) to which they may become subject under the
Securities Act, the Exchange Act or other federal or state law, insofar as such
losses, claims, damages, or liabilities (or actions in respect thereof) arise
out of or are based upon any of the following statements, omissions or
violations (each, a "Violation"): (i) any untrue statement or alleged untrue
statement of a material fact contained in such registration statement, including
any preliminary prospectus or final prospectus contained therein or any
amendments or supplements thereto, (ii) the omission or alleged omission to
state therein a material fact required to be stated therein, or necessary to
make the statements therein not misleading, or (iii) any violation or alleged
violation by the Company of the Securities Act, the Exchange Act, any state
securities law or any rule or regulation promulgated under the Securities Act,
the Exchange Act or any state securities law; and the Company will pay to each
such Holder, officer, director, partner, legal counsel, accountant, underwriter
or controlling person, as incurred, any legal or other expenses reasonably
incurred by them in connection with investigating or defending any such loss,
claim, damage, liability, or action; provided, however, that the indemnity
agreement contained in this subsection 1.10(a) shall not apply to amounts paid
in settlement of any such loss, claim, damage, liability, or action if such
settlement is effected without the consent of the Company (which consent shall
not be unreasonably withheld), nor shall the Company be liable to any Holder,
officer, director, partner, legal counsel, accountant, underwriter or
controlling person for any such loss, claim, damage, liability, or action to the
extent that it arises out of or is based upon a Violation which occurs in
reliance upon and in conformity with written information furnished expressly for
use in connection with such registration by any such Holder, underwriter or
controlling person.

         (b) To the extent permitted by law, each selling Holder will indemnify
and hold harmless the Company, each of its directors, each of its officers who
has signed the registration statement, legal counsel and accountant, each
person, if any, who controls the Company within the meaning of the Securities
Act, any underwriter, any other Holder selling securities in such registration
statement and any controlling person of any such underwriter or other Holder,
against any losses, claims, damages, or liabilities (joint or several) to which
any of the foregoing persons may become subject, under the Securities Act, the
Exchange Act or other federal or state law, insofar as such losses, claims,
damages, or liabilities (or actions in respect thereto) arise out of or are
based upon any Violation, in each case to the extent (and only to the extent)
that such Violation occurs in reliance upon and in conformity with written
information furnished by such Holder expressly for use in connection with such
registration; and each such Holder will pay, as incurred, any legal or other

                                       9
<PAGE>

expenses reasonably incurred by any person indemnified pursuant to this
subsection 1.10(b), in connection with investigating or defending any such loss,
claim, damage, liability, or action; provided, however, that the indemnity
agreement contained in this subsection 1.10(b) shall not apply to amounts paid
in settlement of any such loss, claim, damage, liability or action if such
settlement is effected without the consent of the Holder, which consent shall
not be unreasonably withheld; provided, that in no event shall any indemnity
under this subsection 1.10(b) exceed the net proceeds from the offering received
by such Holder.

         (c) Promptly after receipt by an indemnified party under this Section
1.10 of notice of the commencement of any action (including any governmental
action) or, if sooner, promptly after such indemnified party has actual
knowledge of any claim as to which indemnity may be sought, such indemnified
party will, if a claim in respect thereof is to be made against any indemnifying
party under this Section 1.10, deliver to the indemnifying party a written
notice of the commencement thereof and the indemnifying party shall have the
right to participate in, and, to the extent the indemnifying party so desires,
jointly with any other indemnifying party similarly noticed, to assume the
defense thereof with counsel mutually satisfactory to the parties; provided,
however, that an indemnified party (together with all other indemnified parties
which may be represented without conflict by one counsel) shall have the right
to retain one separate counsel, with the reasonable fees and expenses to be paid
by the indemnifying party, if representation of such indemnified party by the
counsel retained by the indemnifying party would be inappropriate due to actual
or potential differing interests between such indemnified party and any other
party represented by such counsel in such proceeding. The failure to deliver
written notice to the indemnifying party within a reasonable time of the
commencement of any such action, if prejudicial to its ability to defend such
action, shall relieve such indemnifying party of any liability to the
indemnified party under this Section 1.10, but the omission so to deliver
written notice to the indemnifying party will not relieve it of any liability
that it may have to any indemnified party otherwise than under this Section
1.10. No Indemnifying Party, in the defense of any such claim or litigation,
shall, except with the consent of each Indemnified Party, consent to entry of
any judgment or enter into any settlement which does not include as an
unconditional term thereof the giving by the claimant or plaintiff to such
Indemnified Party of a release from all liability in respect to such claim or
litigation.

         (d) If the indemnification provided for in this Section 1.10 is held by
a court of competent jurisdiction to be unavailable to an indemnified party with
respect to any loss, liability, claim, damage or expense referred to therein,
then the indemnifying party, in lieu of indemnifying such indemnified party
hereunder, shall contribute to the amount paid or payable by such indemnified
party as a result of such loss, liability, claim, damage, or expense in such
proportion as is appropriate to reflect the relative fault of the indemnifying
party on the one hand and of the indemnified party on the other in connection
with the statements or omissions that resulted in such loss, liability, claim,
damage or expense as well as any other relevant equitable considerations;
provided, that in no event shall any contribution by a Holder under this
subsection 1.10(d) exceed the net proceeds from the offering received by such
Holder. The relative fault of the indemnifying party and of the indemnified
party shall be determined by reference to, among other things, whether the
untrue or alleged untrue statement of a material fact or the omission to state a
material fact relates to information supplied by the indemnifying party or by

                                       10
<PAGE>

the indemnified party and the parties' relative intent, knowledge, access to
information, and opportunity to correct or prevent such statement or omission.

         (e) Notwithstanding the foregoing, to the extent that the provisions on
indemnification and contribution contained in the underwriting agreement entered
into in connection with the underwritten public offering are in conflict with
the foregoing provisions, the provisions in the underwriting agreement shall
control.

         (f) The obligations of the Company and Holders under this Section 1.10
shall survive the completion of any offering of Registrable Securities in a
registration statement and the termination of this Agreement.

         1.11 Reports Under Securities Exchange Act of 1934. With a view to
making available to the Holders the benefits of Rule 144 promulgated under the
Securities Act and any other rule or regulation of the SEC that may at any time
permit a Holder to sell securities of the Company to the public without
registration or pursuant to a registration on Form S-3, the Company agrees to:

         (a) make and keep public information available, as those terms are
understood and defined in SEC Rule 144, at all times after ninety (90) days
after the effective date of the first registration statement filed by the
Company for the offering of its securities to the general public so long as the
Company remains subject to the periodic reporting requirements under Sections 13
or 15(d) of the Exchange Act;

         (b) take such action, including the voluntary registration of its
Common Stock under Section 12 of the Exchange Act, as is necessary to enable the
Holders to utilize Form S-3 for the sale of their Registrable Securities, such
action to be taken as soon as practicable after the end of the fiscal year in
which the first registration statement filed by the Company for the offering of
its securities to the general public is declared effective;

         (c) file with the SEC in a timely manner all reports and other
documents required of the Company under the Securities Act and the Exchange Act;
and

         (d) furnish to any Holder, so long as the Holder owns any Registrable
Securities, forthwith upon request (i) a written statement by the Company that
it has complied with the reporting requirements of SEC Rule 144 (at any time
after ninety (90) days after the effective date of the first registration
statement filed by the Company), the Securities Act and the Exchange Act (at any
time after it has become subject to such reporting requirements), or that it
qualifies as a registrant whose securities may be resold pursuant to Form S-3
(at any time after it so qualifies), (ii) a copy of the most recent annual or
quarterly report of the Company and such other reports and documents so filed by
the Company, and (iii) such other information as may be reasonably requested in
availing any Holder of any rule or regulation of the SEC which permits the
selling of any such securities without registration or pursuant to such form.

         1.12 Foreign Registration. If the Company effectuates a Qualified IPO
outside of the United States, it will take such actions and file such documents
as may be necessary to afford the same level of liquidity to the Holders of
Registrable Securities as would be afforded under this Agreement if the Company
were to have effectuated a Qualified IPO within the United States.

                                       11
<PAGE>

         1.13 Limitations on Subsequent Registration Rights. From and after the
date of this Agreement, the Company shall not, without the prior written consent
of a majority of the Series B Holders, enter into any agreement with any holder
or prospective holder of any securities of the Company which would allow such
holder or prospective holder (a) to include such securities in any registration
filed under Section 1.2 or 1.3 hereof, unless under the terms of such agreement,
such holder or prospective holder may include such securities in any such
registration only to the extent that the inclusion of his securities will not
reduce the amount of the Registrable Securities of the Series B Holders which is
included, (b) to make a demand registration which could result in such
registration statement being declared effective prior to the earlier of either
of the dates set forth in subsection 1.2(a) or within one hundred twenty (120)
days of the effective date of any registration effected pursuant to Section 1.2,
or (c) to request a registration on Form S-3.

         1.14 "Market Stand-Off" Agreement. Each Holder hereby agrees that,
during the period of duration (up to, but not exceeding, 180 days) specified by
the Company and an underwriter of Common Stock or other securities of the
Company, following the effective date of a registration statement of the Company
filed under the Securities Act, it shall not, to the extent requested by the
Company and such underwriter, directly or indirectly sell, offer to sell,
contract to sell (including, without limitation, any short sale), grant any
option to purchase or otherwise transfer or dispose of (other than to donees who
agree to be similarly bound) any securities of the Company held by it at any
time during such period except Common Stock included in such registration;
provided, however, that:

         (a) such agreement shall be applicable only to the first such
registration statement of the Company which covers Common Stock (or other
securities) to be sold on its behalf to the public in an underwritten offering;
and

         (b) all officers and directors of the Company, all one-percent (1%)
securityholders, and all other persons with registration rights (whether or not
pursuant to this Agreement) enter into and remain bound by similar agreements.

         In order to enforce the foregoing covenant, the Company may impose stop
transfer instructions with respect to the Registrable Securities of each Holder
(and the shares or securities of every other person subject to the foregoing
restriction) until the end of such period, and each Holder agrees that, if so
requested, such Holder will execute an agreement in the form provided by the
underwriter containing terms which are essentially consistent with the
provisions of this Section 1.14.

         Notwithstanding the foregoing, the obligations described in this
Section 1.15 shall not apply to a registration relating solely to employee
benefit plans on Form S-1 or Form S-8 or similar forms which may be promulgated
in the future, or a registration relating solely to an SEC Rule 145 transaction
on Form S-4 or similar forms which may be promulgated in the future.

                                       12
<PAGE>

         Furthermore, notwithstanding the foregoing, the Market Stand-Off
provisions contained in this Section 1.14 shall not apply to shares of Common
Stock purchased by a Holder in or after the Company's initial public offering.

         1.15 Termination of Registration Rights. No Holder shall be entitled to
exercise any right provided for in this Section 1 after such time as Rule 144 or
another similar exemption under the Securities Act is available for the sale of
all of such Holder's shares during a ninety (90) day period without
registration.

         2. Covenants of the Company.

         2.1 Delivery of Financial Statements. The Company shall deliver to each
Investor:

         (a) as soon as practicable, but in any event within sixty (60) days
after the end of each fiscal year of the Company, an income statement for such
fiscal year, a balance sheet of the Company and statement of stockholders'
equity as of the end of such year, and a statement of cash flows for such year,
such year-end financial reports to be in reasonable detail, prepared in
accordance with generally accepted accounting principles ("GAAP"), and audited
and certified by an independent public accounting firm of nationally recognized
standing selected by the Company;

         (b) as soon as practicable, but in any event within thirty (30) days
after the end of each of the first three (3) quarters of each fiscal year of the
Company, an unaudited profit or loss statement, a statement of cash flows for
such fiscal quarter, a summary of bookings and backlog and an unaudited balance
sheet as of the end of such fiscal quarter;

         (c) as soon as practicable, but in any event within fifteen (15) days
of the end of each month, a monthly management report, in a form to be
determined by the Board; provided that the Company shall only be required to
provide such management report to Investors owning at least ten percent (10%) of
the Company's issued and outstanding capital stock;

         (d) with reasonable promptness, such other information and data with
respect to the Company and its subsidiaries as any Investor may reasonably
request from time to time; and

         (e) with respect to the financial statements called for in subsections
(b) and (c) of this Section 2.1, an instrument executed by the Chief Financial
Officer or Chief Executive Officer of the Company and certifying that such
financials were prepared in accordance with GAAP consistently applied with prior
practice for earlier periods (with the exception of footnotes that may be
required by GAAP) and fairly present the financial condition of the Company and
its results of operation for the period specified, subject to normal and
recurring year-end audit adjustment, provided that the foregoing shall not
restrict the right of the Company to change its accounting principles consistent
with GAAP, if the Board of Directors including the members thereof elected by
the holders of the Company's Series B Preferred Stock determines that it is in
the best interest of the Company to do so.

                                       13
<PAGE>

Each Investor hereby agrees to hold in confidence and trust and not to misuse or
disclose any confidential information provided pursuant to this Section 2.1
unless required by applicable law or a court order.

         2.2 Inspection. The Company shall, upon reasonable prior notice, permit
each Investor, at such Investor's expense, to visit and inspect the Company's
properties, to examine its books of account and records and to discuss the
Company's affairs, finances and accounts with its officers, all at such
reasonable times as may be requested by the Investor; provided, however, that
the Company shall not be obligated pursuant to this Section 2.2 to provide
access to any information which it reasonably considers to be a trade secret or
similar confidential information.

         2.3 Right of First Refusal. The Company hereby grants to each of Proton
Marketing Associates LLC, Putchkon.com LLC, Chinese Whispers LLC, Ogen LLC,
Doron Cohen, Irit Cohen, Yuval Horn and each Holder who owns any Series B
Preferred Stock or Series A Preferred Stock (or any shares of Common Stock
issued upon conversion of the Series B Preferred Stock or Series A Preferred
Stock) (collectively, the "Major Investors") the right of first refusal to
purchase a pro rata share of New Securities (as defined below) which the Company
may, from time to time, propose to sell and issue. A Major Investor's pro rata
share, for purposes of this right of first refusal, is the ratio of the number
of shares of Common Stock owned by such Major Investor immediately prior to the
issuance of New Securities to the total number of shares of Common Stock
outstanding immediately prior to the issuance of New Securities, assuming in
each case full conversion of the Series A Preferred Stock and Series B Preferred
Stock (including those that may be acquired by exercise of the Warrants) and
exercise of all outstanding rights, options and warrants to acquire Common Stock
of the Company. Each Major Investor shall have a right of over-allotment such
that if any Major Investor fails to exercise its right hereunder to purchase its
pro rata share of New Securities, the other Major Investors may purchase the
non-purchasing Major Investor's portion on a pro rata basis within ten (10) days
from the date such non-purchasing Major Investor fails to exercise its right
hereunder to purchase its pro rata share of New Securities.

         This right of first refusal shall be subject to the following
provisions:

         (a) "New Securities" shall mean any capital stock (including Common
Stock and/or Series A Preferred Stock and/or Series B Preferred Stock) of the
Company whether now authorized or not, and rights, options or warrants to
purchase such capital stock, and securities of any type whatsoever that are, or
may become, convertible into capital stock; provided that the term "New
Securities" does not include (i) securities purchased under the Purchase
Agreement; (ii) securities issued upon conversion of the Series A Preferred
Stock or Series B Preferred Stock or exercise of the Warrants; (iii) securities
issued pursuant to the acquisition of another business entity or business
segment of any such entity by the Company by merger, purchase of substantially
all the assets or other reorganization whereby the Company will own not less
than fifty-one percent (51%) of the voting power of such business entity or
business segment of any such entity; (iv) shares of Common Stock issued or
issuable to employees, consultants, officers or directors of the Company
pursuant to any stock option, stock purchase or stock bonus plan, agreement or
arrangement approved by the Board of Directors; (v) securities issued to vendors
or customers or to other persons in similar commercial situations with the

                                       14
<PAGE>

Company if such issuance is approved by the Board of Directors, including the
directors designated by the Series B Holders; (vi) securities issued to a
strategic investor, if such issuance is approved by the Board of Directors,
including the directors designated by the Series B Holders; (vii) securities
issued in a firm commitment underwritten public offering pursuant to a
registration under the Securities Act with an aggregate offering price to the
public in excess of $7.5 million; (viii) securities issued in connection with
any stock split, stock dividend or recapitalization of the Company; and (ix) any
right, option or warrant to acquire any security convertible into the securities
excluded from the definition of New Securities pursuant to subsections (i)
through (viii) above.

         (b) In the event the Company proposes to undertake an issuance of New
Securities, it shall give each Major Investor written notice of its intention,
describing the type of New Securities, and their price and the general terms
upon which the Company proposes to issue the same. Each Major Investor shall
have twenty (20) days after any such notice is effective to agree to purchase
such Major Investor's pro rata share of such New Securities for the price and
upon the terms specified in the notice by giving written notice to the Company
and stating therein the quantity of New Securities to be purchased.

         (c) In the event the Major Investors fail to exercise fully the right
of first refusal within said twenty (20)-day period and after the expiration of
the ten day period for the exercise of the over-allotment provisions of this
Section 2.3, the Company shall have sixty (60) days thereafter to sell or enter
into an agreement (pursuant to which the sale of New Securities covered thereby
shall be closed, if at all, within sixty (60) days from the date of said
agreement) to sell the New Securities respecting which the Major Investors'
right of first refusal option set forth in this Section 2.3 was not exercised,
at a price and upon terms no more favorable to the purchasers thereof than
specified in the Company's notice to the Major Investors pursuant to Section
2.3(b). In the event the Company has not sold within said 60-day period or
entered into an agreement to sell the New Securities within said 60-day period
(or sold and issued New Securities in accordance with the foregoing within sixty
(60) days from the date of said agreement), the Company shall not thereafter
issue or sell any New Securities, without first again offering such securities
to the Major Investors in the manner provided in Section 2.3(b) above.

         (d) The right of first refusal set forth in this Section 2.3 may not be
assigned or transferred, except that (i) such right is assignable by each Major
Investor to any wholly owned subsidiary or parent of, or to any corporation or
entity that is, within the meaning of the Securities Act, controlling,
controlled by or under common control with, any such Major Investor, and (ii)
such right is assignable between and among any of the Major Investors.

         2.4 Key Person Life Insurance. Within thirty (30) days of the date
hereof, the Company will obtain from financially sound and reputable insurers
term life insurance on the life of Shay Ben Asulin in the amount of $1,000,000
and Mordecai Brudo in the amount of $1,000,000. The Company will cause to be
maintained the term life insurance required by this Section 2.4, except as
otherwise decided in accordance with policies adopted by the Company's Board of
Directors. Such policies shall name the Company as loss payee and shall not be
cancelable by the Company without prior approval of the Board of Directors,
including the directors designated by each of e-street and DEP.

                                       15
<PAGE>

         2.5 Proprietary Information and Inventions Agreements. The Company will
cause each of its current or future officers, directors, employees, consultants
and advisors and those of any subsidiary with access to confidential information
to enter into a proprietary information and inventions agreement substantially
in the form approved by the Board of Directors.

         2.6 Publication. Upon request of e-street or DEP, the Company will
include in any advertisement, news release, statement made in any professional
or trade publication or other public disclosure, as e-street or DEP may request,
the statement that it is a member of the Sintek Capital group and/or the DEP
group, as the case may be, and/or the Sintek Capital group logo or DEP group
logo, as the case may be; provided, however, that the final form of any such
publication shall be approved in advance by e-street and DEP; and provided,
further, that the Company may omit such statement(s) and/or logo(s) if there is
a reasonable basis therefor and if it has provided reasonable notice to e-street
and DEP of such omission prior to the issuance of any advertisement, news
release, statement made in any professional or trade publication or other public
disclosure.

         2.7 Termination of Covenants. The covenant set forth in this Section 2
shall terminate as to each Investor and be of no further force or effect
immediately prior to the consummation of a Qualified IPO.

         3. Miscellaneous.

         3.1 Successors and Assigns. Except as otherwise provided in this
Agreement, the terms and conditions of this Agreement shall inure to the benefit
of and be binding upon the respective successors and permitted assigns of the
parties (including transferees of any of the Series A Preferred Stock, Series B
Preferred Stock or Warrants or any Series B Preferred Stock or Common Stock
issued upon conversion or exercise thereof). Nothing in this Agreement, express
or implied, is intended to confer upon any party other than the parties hereto
or their respective successors and assigns any rights, remedies, obligations, or
liabilities under or by reason of this Agreement, except as expressly provided
in this Agreement. The rights hereunder may be assigned by any Series B Holder
to another Series B Holder or an investor in such Series B Investor, by an
Investor to the ancestors, descendants or spouse or to trusts for the benefit of
such persons or such Investor or a charitable remainder trust, or by an Investor
to a partner or an affiliate of such Investor.

         3.2 Amendments and Waivers. Any term of this Agreement may be amended
or waived only with the written consent of the Company, e-street and DEP. Any
amendment or waiver effected in accordance with this paragraph shall be binding
upon every party to this Agreement.

         3.3 Notices. All notices required or permitted hereunder shall be in
writing and shall be deemed effectively given: (a) upon personal delivery to the
party to be notified; (b) when sent by confirmed telex or facsimile if sent
during normal business hours of the recipient, if not, then on the next business
day; (c) five (5) days after having been sent by registered or certified mail,
return receipt requested, postage prepaid; or (d) one (1) day after deposit with
a nationally recognized overnight courier, specifying next day delivery, with
written verification of receipt. All communications shall be sent to the address
as set forth on Exhibit A hereof or at such other address as such party may
designate by ten (10) days advance written notice to the other parties hereto.

                                       16
<PAGE>

         3.4 Effect of Change in Company's Capital Structure. Appropriate
adjustments shall be made in the number and class of shares subject to any
provision of this Agreement in the event of a stock dividend, stock split,
reverse stock split, combination, reclassification or like change in the capital
structure of the Company.

         3.5 Attorney Fees. In the event that any dispute among the parties to
this Agreement should result in litigation, the prevailing party in such dispute
shall be entitled to recover from the losing party all fees, costs and expenses
of enforcing any right of such prevailing party under or with respect to this
Agreement, including without limitation, such reasonable fees and expenses of
attorneys and accountants, which shall include, without limitation, all fees,
costs and expenses of appeals.

         3.6 Severability. If one or more provisions of this Agreement are held
to be unenforceable under applicable law, the parties agree to renegotiate such
provision in good faith. In the event that the parties cannot reach a mutually
agreeable and enforceable replacement for such provision, then (a) such
provision shall be excluded from this Agreement, (b) the balance of the
Agreement shall be interpreted as if such provision were so excluded and (c) the
balance of the Agreement shall be enforceable in accordance with its terms.

         3.7 Governing Law. This Agreement and all acts and transactions
pursuant hereto shall be governed, construed and interpreted in accordance with
the laws of the State of New York, without giving effect to principles of
conflicts of laws.

         3.8 Counterparts. This Agreement may be executed in two or more
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument.

         3.9 Titles and Subtitles. The titles and subtitles used in this
Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement.

         3.10 Aggregation of Stock. All shares of the Series A Preferred Stock
or Series B Preferred Stock held or acquired by (i) affiliated entities or
persons or (ii) persons or entities under common investment management, shall be
aggregated together for the purpose of determining the availability of any
rights under this Agreement.

         3.11 Specific Enforcement. It is agreed and understood that monetary
damages would not adequately compensate an injured party for the breach of this
Agreement by any party, that this Agreement shall be specifically enforceable,
and that any breach or threatened breach of this Agreement shall be the proper
subject of a temporary or permanent injunction or restraining order. Further,
each party hereto waives any claim or defense that there is an adequate remedy
at law for such breach or threatened breach.

         3.12 Entire Agreement; Superseding Effect. This Agreement and the
Waiver constitute the entire agreement between and among the parties hereto
pertaining to the subject matter hereof and any other written or oral agreements
between and among the parties hereto pertaining thereto are expressly cancelled.

                            [Signature Page Follows]

                                       17
<PAGE>

         The parties have executed this Investors' Rights Agreement as of the
date first above written.

COMPANY:

M-WISE, INC.

By: /s/ Shay Ben-Asulin
Name:  Shay Ben-Asulin
Title: Chairman
Address:

INVESTORS:

PROTON MARKETING ASSOCIATES LLC

By:      /s/ Mati Brudo
Name:    Mati Brudo
Title:
Address:

PUTCHKON.COM LLC

By:      Shay Ben-Asulin
Name:    Shay Ben Asulin
Title:
Address:

CHINESE WHISPERS LLC

By:      /s/ James Crossley
Name:    James Crossley
Title:
Address:

<PAGE>

OGEN LLC

By:      /s/ Nir Frishman
Name:    Nir Frishman
Title:
Address:

By:      /s/ Barak Galili
Name:    Barak Galili
Title:
Address:

CAP VENTURES LTD.

By:      /s/ Dr. Michael Anghel
Name:    Dr. Michael Anghel
Title:
Address:

E-STREET INTERNATIONAL AG

By:
   --------------------------------------------
Name:
Title:
Address:

D.E.P. TECHNOLOGY HOLDINGS LTD

By:
   --------------------------------------------
Name:
Title:
Address:

-----------------------------------------------
Doron Cohen

-----------------------------------------------
Irit Cohen

-----------------------------------------------
Yuval Horn

                                       2
<PAGE>

                                    EXHIBIT A

                                    INVESTORS

                  Name/Address/Fax No.

                  e-street international ag
                  Zugspitzstrasse 15
                  Pullach 82049
                  Germany

                  Notices shall be addressed as follows:

                  Amadeo Carassai
                  Sintek Group
                  Via Dukini 28
                  Milan 20122
                  Italy
                  Telephone No:  (39) 02-7627-0303
                  Facsimile No:   (39) 02-7627-0334

                  D.E.P. Technology Holdings Ltd
                  The Triangle Building, 42nd Floor
                  3 Azrieli Center
                  Tel Aviv 67023
                  Attention: Yaron Tal, Chief Financial Officer
                  Telephone No:  (972) 3-607-5555
                  Facsimile No:  (972) 3-607-5556<PAGE>

                                                                   EXHIBIT 10.17

                             STOCKHOLDERS' AGREEMENT

                  This Stockholders' Agreement is made as of the 11th day of
January, 2001 by and among m-Wise, Inc., a Delaware corporation (the "Company"),
the investors listed on Schedule A hereto (each, a "Series A Investor" and
collectively, the "Series A Investors"), the investors listed on Schedule B
hereto (or any subsidiary thereof, any entity into which any such investor shall
merge or any subsidiary of such entity) (each, a "Series B Investor" and
collectively, the "Series B Investors"), Proton Marketing Associates LLC,
Putchkon.com LLC, Chinese Whispers LLC and Ogen LLC (each, a "Founder" and
collectively, the "Founders"), each of which owns the number of shares set forth
opposite its name on Schedule C hereto, and the stockholders listed on Schedule
D hereto (the "Other Stockholders"). The Founders, the Other Stockholders, the
Series A Investors and the Series B Investors shall be referred to collectively
herein as the "Stockholders."

                  WHEREAS, the Series A Investors possess certain first refusal,
co-sale, bring-along and board representation rights pursuant to a Subscription
Agreement dated as of April 12, 2000, as amended, among the Company and the
Series A Investors (the "Subscription Agreement") and as set forth in the
Certificate of Designation, Preferences and Rights of the Series A Preferred
Stock, par value $0.01 per share (the "Series A Preferred Stock"), of the
Company;

                  WHEREAS, pursuant to a waiver and termination agreement dated
as of the date hereof (the "Waiver"), the Series A Investors have agreed, among
other things, to terminate such rights under the Subscription Agreement and as
set forth in the Certificate of Designation, Preferences and Rights of the
Series A Preferred Stock, and to accept the rights created pursuant hereto in
lieu thereof;

                  WHEREAS, the Series A Investors are the beneficial owners of
the number of shares of Series A Preferred Stock and warrants to purchase shares
of Series A Preferred Stock of the Company set forth opposite their names on
Schedule A attached hereto;

                  WHEREAS, the Company and the Series B Investors are parties to
a Purchase Agreement of even date herewith (the "Purchase Agreement"), pursuant
to which the Series B Investors are purchasing shares of Series B Preferred
Stock, par value $0.01 per share (the "Series B Preferred Stock") of the Company
and warrants to purchase shares of Series B Preferred Stock, in the amounts and
for the aggregate exercise price set forth opposite their names on Schedule B
attached hereto;

                  WHEREAS, the Founders are the beneficial owners of the number
of shares of Common Stock of the Company set forth opposite their names on
Schedule C attached hereto;

                  WHEREAS, the Other Stockholders are the beneficial owners of
the number of shares of Common Stock of the Company set forth opposite their
names on Schedule D attached hereto; and

<PAGE>

                  WHEREAS, it is a condition precedent to the transactions
contemplated by the Purchase Agreement that the Company, the Founders, the Other
Stockholders, the Series A Investors and the Series B Investors enter into this
agreement;

                  NOW, THEREFORE, in consideration of the mutual covenants set
forth herein, the parties agree as follows:

                  1. Definitions.

                       (a) "Common Stock" shall mean the Company's Common Stock,
including, without limitation, shares of Common Stock issued or issuable upon
conversion of (i) the Company's Preferred Stock or (ii) any other security
convertible into shares of the Company's Common Stock.

                       (b) "Founder Stock" shall mean shares of the Company's
Common Stock now owned or subsequently acquired by the Founders.

                       (c) "Preferred Stock" shall mean the Company's
outstanding Series A Preferred Stock and Series B Preferred Stock.

                       (d) "Investor Stock" shall mean shares of the Company's
Common Stock and Preferred Stock now owned or subsequently acquired by the
Series A Investors and the Series B Investors.

                       (e) "Preferred Stockholder" shall mean the holders of the
Company's Preferred Stock.

                  2. Restrictions on Transfer. None of the Founders, the Other
Stockholders, the Series A Investors or the Series B Investors will sell,
assign, transfer, pledge, hypothecate or otherwise encumber or dispose of in any
way ("Transfer"), all or any part of or any interest in the Founder Stock,
Common Stock or Investor Stock, as the case may be, now or hereafter owned or
held by any of them in violation of the terms of this Agreement. Any Transfer of
Founder Stock, Common Stock or Investor Stock not made in conformance with this
Agreement shall be null and void, shall not be recorded on the books of the
Company and shall not be recognized by the Company.

                  3. Sales by Founders.

                       (a) Restrictions. None of the Founders shall Transfer any
shares of Founder Stock prior to January 11, 2005, except as specifically
provided for in Section 8, without the prior written consent of the holders of
at least a majority of the Series B Preferred Stock; provided, however, that
each of the Founders may Transfer (i) at any time after January 11, 2003 and
prior to January 11, 2005, a number of shares of Founder Stock not in excess of
ten percent (10%) of the number of shares set forth opposite its name on
Schedule C and (ii) at any time after January 11, 2004 and prior to January 11,
2005, an additional number of shares of Founder Stock not in excess of the sum
of (A) fifteen percent (15%) of the number of shares set forth opposite its name
on Schedule C and (B) such number of shares of Founder Stock permitted to be
Transferred pursuant to clause (i) above and not so Transferred. Any Transfers
made by the Founders pursuant to this Section 3(a) shall be subject to the
remaining terms and conditions of this Agreement.

                                       2
<PAGE>

                       (b) Series B Right of First Refusal.
                           --------------------------------

                           (i) If a Founder proposes to Transfer any shares of
Founder Stock, whether prior to January 11, 2005 in accordance with Section 3(a)
or thereafter, then such Founder shall offer such shares first to the Series B
Investors, by sending written notice (the "Notice") to the Series B Investors,
with a copy to the Company and the Series A Investors, which shall state (A) the
number of shares proposed to be Transferred (the "Offered Stock"), (B) the
identity of the proposed transferee ("Third Party Purchaser"), (C) the proposed
purchase price per share offered by the Third Party Purchaser (the "Offer
Price"), and (D) the material terms and conditions upon which the proposed
Transfer is to be made. Upon delivery of the Notice, such offer shall be
irrevocable unless and until the rights of first offer provided for herein shall
have been waived or shall have expired.

                           (ii) The Series B Investors may elect, by written
notice to the Founder and the Company delivered within fifteen (15) days after
the giving of the Notice pursuant to Section 3(b)(i) (the "Series B Notice
Period"), to purchase any or all of the Offered Stock at a purchase price equal
to the Offer Price and upon the terms and subject to the conditions set forth in
the Notice (the "Series B Option"). Each Series B Investor shall have the right
to purchase that percentage of the Offered Stock determined by dividing (A) the
total number of shares of Investor Stock then owned by such Series B Investor by
(B) the total number of shares of Investor Stock then owned by all Series B
Investors (in each case, calculated on an as converted to Common Stock basis).
The Company shall, within five (5) days of the expiration of the Series B Notice
Period, provide written notice to the fully participating Series B Investors
indicating the number of shares of Offered Stock not elected to be purchased by
the other Series B Investors (the "Company B Option Notice"). If any Series B
Investor does not fully subscribe for the number of shares of Offered Stock such
Series B Investor is entitled to purchase, then each other fully participating
Series B Investor may elect by written notice delivered to the Founder and the
Company within five (5) days of delivery of the Company B Option Notice to
purchase that percentage of the remaining Offered Stock not so subscribed for
determined by dividing (x) the total number of shares of Investor Stock then
owned by such fully participating Series B Investor by (y) the total number of
shares of Investor Stock then owned by all fully participating Series B
Investors who elected to purchase the remaining Offered Stock (in each case,
calculated on an as converted to Common Stock basis).

                           (iii) The failure of a Series B Investor to respond
within the Series B Notice Period to the Founder and the Company shall be deemed
to be a waiver of such Series B Investor's rights under this Section 3(b),
provided that each Series B Investor may waive its rights under this Section
3(b) prior to the expiration of the Series B Notice Period by giving written
notice to the Founder and the Company.

                                       3
<PAGE>

                       (c) Series A Right of First Refusal.
                           --------------------------------

                           (i) The Company shall within five (5) days of the
expiration of the last applicable time period set forth in Section 3(b)(ii)
above provide notice to the Series A Investors of the number of shares of
Offered Stock, if any, that the Series B Investors did not elect to purchase.
The Series A Investors may elect within fifteen (15) days after delivery of such
notice (the "Series A Notice Period") to purchase any or all of the remaining
Offered Stock at a purchase price equal to the Offer Price and upon the terms
and subject to the conditions set forth in the Notice (the "Series A Option").
Each such Series A Investor shall have the right to purchase that percentage of
the remaining Offered Stock determined by dividing (x) the total number of
shares of Investor Stock then owned by such Series A Investor by (y) the total
number of shares of Investor Stock then owned by all Series A Investors (in each
case, calculated on an as converted to Common Stock basis). The Company shall,
within five (5) days of the expiration of the Series A Notice Period, provide
written notice to the fully participating Series A Investors indicating the
number of shares of Offered Stock not elected to be purchased by the other
Series A Investors (the "Company A Option Notice"). If any Series A Investor
does not fully subscribe for the number of shares of Offered Stock such Series A
Investor is entitled to purchase, then each other fully participating Series A
Investor may elect by written notice delivered to the Founder and the Company
within five (5) days of delivery of the Company A Option Notice to purchase that
percentage of the remaining Offered Stock not so subscribed for determined by
dividing (I) the total number of shares of Investor Stock then owned by such
fully participating Series A Investor by (II) the total number of shares of
Investor Stock then owned by all fully participating Series A Investors who
elected to purchase the remaining Offered Stock (in each case, calculated on an
as converted to Common Stock basis).

                           (ii) The failure of a Series A Investor to respond
within the Series A Notice Period to the Founder and the Company shall be deemed
to be a waiver of such Series A Investor's rights under this Section 3(c),
provided that each Series A Investor may waive its rights under this Section
3(c) prior to the expiration of the Series A Notice Period by giving written
notice to the Founder and the Company.

                       (d) Settlement.
                           -----------

                           (i) The Closing of the Offered Stock to be purchased
by the Series B Investors and/or the Series A Investors shall be completed
within thirty (30) days of the expiration of the last applicable notice period
set forth in Sections 3(b) or (c), as applicable.

                           (ii) Unless the Series B Investors or the Series A
Investors shall have purchased all of the Offered Stock pursuant to Sections
3(b) or (c), as applicable, the Founder may, subject to Section 3(e), sell the
Offered Stock to a Third Party Purchaser on the terms and subject to the
conditions set forth in the Notice; provided, however, that such sale is bona
fide and made pursuant to a contract entered into within sixty (60) days of the
earliest to occur of (A) the waiver by the Series B Investors and the Series A
Investors of their options to purchase the Offered Stock or (B) the expiration
of the Series A Notice Period or (C) the expiration of the time period set forth
in Section 3(d)(i) without the closing of the purchase of the Offered Stock
having taken place due to failure by the Series A Investors and/or Series B
Investors to close (the earliest of such dates being referred to herein as the
"Contract Date"); and provided further, that such sale shall not be consummated
unless and until all of the following conditions are met:

                                       4
<PAGE>

                           (a)      The Founder shall deliver to the Company a
                                    certificate of a Third Party Purchaser
                                    stating that (x) such Third Party Purchaser
                                    is aware of the rights of the Series B
                                    Investors and the Series A Investors
                                    contained in this Section 3 and (y) prior to
                                    the purchase by such Third Party Purchaser
                                    of any of such Offered Stock, such Third
                                    Party Purchaser shall become a party to this
                                    Agreement and agree to be bound by the terms
                                    and conditions hereof; and

                           (b)      The consummation of such sale to a Third
                                    Party Purchaser shall not be subject to any
                                    conditions (other than necessary filings
                                    under the Hart-Scott-Rodino Antitrust
                                    Improvements Act), except that it may be
                                    conditioned upon the truth as of the closing
                                    of the proposed purchase of customary
                                    representations and warranties and the
                                    delivery of stock certificates and a
                                    customary legal opinion.

                           (iii) If such sale is not consummated within sixty
(60) days of the Contract Date for any reason, then the restrictions provided
for herein shall again become effective, and no Transfer of such Offered Stock
may be made thereafter by the Founder without again offering the same to the
Series B Investors and the Series A Investors in accordance with this Section 3.

                       (e) Co-Sale Right.
                           --------------

                           (i) If a Founder is Transferring stock to a Third
Party Purchaser pursuant to Section 3(d)(ii), then each Preferred Stockholder
that has not exercised the Series B Option or the Series A Option, as
applicable, shall have the right, exercisable upon written notice to such
Founder within thirty (30) days after receipt of the Notice, to participate in
such sale of Founder Stock on the same terms and conditions. To the extent one
or more of the Preferred Stockholders exercise such right of participation in
accordance with the terms and conditions set forth below, the number of shares
of Founder Stock that the Founder may sell in the transaction shall be
correspondingly reduced.

                           (ii) Each Preferred Stockholder may sell all or any
part of that number of shares of Investor Stock equal to the product obtained by
multiplying (A) the aggregate number of shares of Founder Stock covered by the
Notice by (B) a fraction, the numerator of which is the number of shares of
Investor Stock owned by the Preferred Stockholder at the time of the Transfer
and the denominator of which is the total number of shares of Investor Stock
owned by all the Preferred Stockholders at the time of the Transfer (in each
case, calculated on an as converted to Common Stock basis).

                           (iii) If any Preferred Stockholder fails to elect to
fully participate in such Founder's sale pursuant to this Section 3(e), the
Founder shall give notice of such failure to the Preferred Stockholders who did
so elect (the "Participants"). The Participants shall have five days from the
date such notice was given to agree to sell their pro rata share of the unsold
portion. For purposes of this paragraph, a Participant's pro rata share shall be
the ratio of (x) the number of shares of Investor Stock held by such Participant
to (y) the total number of shares of Investor Stock held by all the Participants
(in each case, calculated on an as converted to Common Stock basis).

                                       5
<PAGE>

                           (iv) The exercise or non-exercise of the rights of
the Participants hereunder to participate in one or more sales of Founder Stock
made by the Founder shall not adversely affect their rights to participate in
subsequent sales of Founder Stock subject to this Section 3.

                           (v) In the event the Founder has not sold the Founder
Stock subject to the aforementioned provisions within the time period specified
in Section 3(d)(ii), the Founder shall not thereafter sell any Founder Stock
subject to the provisions of this Agreement without again being subject to the
rights of the Stockholders as here prescribed.

                  4. Sales by the Other Stockholders.

                       (a) Series B Right of First Refusal.

                           (i) If an Other Stockholder proposes to Transfer any
shares of Common Stock, then such Other Stockholder shall offer such shares
first to the Series B Investors, by sending written notice (the "Notice") to the
Series B Investors, with a copy to the Company and the Series A Investors, which
shall state (A) the number of shares proposed to be Transferred (the "Offered
Stock"), (B) the identity of the proposed transferee ("Third Party Purchaser"),
(C) the proposed purchase price per share offered by the Third Party Purchaser
(the "Offer Price"), and (D) the material terms and conditions upon which the
proposed Transfer is to be made. Upon delivery of the Notice, such offer shall
be irrevocable unless and until the rights of first offer provided for herein
shall have been waived or shall have expired.

                           (ii) The Series B Investors may elect, by written
notice to the Other Stockholder and the Company delivered within fifteen (15)
days after the giving of the Notice pursuant to Section 4(a)(i) (the "Series B
Notice Period"), to purchase any or all of the Offered Stock at a purchase price
equal to the Offer Price and upon the terms and subject to the conditions set
forth in the Notice (the "Series B Option"). Each Series B Investor shall have
the right to purchase that percentage of the Offered Stock determined by
dividing (A) the total number of shares of Investor Stock then owned by such
Series B Investor by (B) the total number of shares of Investor Stock then owned
by all Series B Investors (in each case, calculated on an as converted to Common
Stock basis). The Company shall, within five (5) days of the expiration of the
Series B Notice Period, provide written notice to the fully participating Series
B Investors indicating the number of shares of Offered Stock not elected to be
purchased by the other Series B Investors (the "Company B Option Notice"). If
any Series B Investor does not fully subscribe for the number of shares of
Offered Stock such Series B Investor is entitled to purchase, then each other
fully participating Series B Investor may elect by written notice delivered to
the Other Stockholder and the Company within five (5) days of delivery of the
Company B Option Notice to purchase that percentage of the remaining Offered
Stock not so subscribed for determined by dividing (x) the total number of
shares of Investor Stock then owned by such fully participating Series B
Investor by (y) the total number of shares of Investor Stock then owned by all
fully participating Series B Investors who elected to purchase the remaining
Offered Stock (in each case, calculated on an as converted to Common Stock
basis).

                                       6
<PAGE>

                           (iii) The failure of a Series B Investor to respond
within the Series B Notice Period to the Other Stockholder and the Company shall
be deemed to be a waiver of such Series B Investor's rights under this Section
4(a), provided that each Series B Investor may waive its rights under this
Section 4(a) prior to the expiration of the Series B Notice Period by giving
written notice to the Other Stockholder and the Company.

                       (b) Series A Right of First Refusal.
                           --------------------------------

                           (i) The Company shall within five (5) days of the
expiration of the last applicable time period set forth in Section 4(a)(ii)
above provide notice to the Series A Investors of the number of shares of
Offered Stock, if any, that the Series B Investors did not elect to purchase.
The Series A Investors may elect within fifteen (15) days after delivery of such
notice (the "Series A Notice Period") to purchase any or all of the remaining
Offered Stock at a purchase price equal to the Offer Price and upon the terms
and subject to the conditions set forth in the Notice (the "Series A Option").
Each such Series A Investor shall have the right to purchase that percentage of
the remaining Offered Stock determined by dividing (x) the total number of
shares of Investor Stock then owned by such Series A Investor by (y) the total
number of shares of Investor Stock then owned by all Series A Investors (in each
case, calculated on an as converted to Common Stock basis). The Company shall,
within five (5) days of the expiration of the Series A Notice Period, provide
written notice to the fully participating Series A Investors indicating the
number of shares of Offered Stock not elected to be purchased by the other
Series A Investors (the "Company A Option Notice"). If any Series A Investor
does not fully subscribe for the number of shares of Offered Stock such Series A
Investor is entitled to purchase, then each other fully participating Series A
Investor may elect by written notice delivered to the Other Stockholder and the
Company within five (5) days of delivery of the Company A Option Notice to
purchase that percentage of the remaining Offered Stock not so subscribed for
determined by dividing (I) the total number of shares of Investor Stock then
owned by such fully participating Series A Investor by (II) the total number of
shares of Investor Stock then owned by all fully participating Series A
Investors who elected to purchase the remaining Offered Stock (in each case,
calculated on an as converted to Common Stock basis).

                           (ii) The failure of a Series A Investor to respond
within the Series A Notice Period to the Other Stockholder and the Company shall
be deemed to be a waiver of such Series A Investor's rights under this Section
4(b), provided that each Series A Investor may waive its rights under this
Section 4(b) prior to the expiration of the Series A Notice Period by giving
written notice to the Other Stockholder and the Company.

                       (c) Settlement.
                           -----------

                           (i) The Closing of the Offered Stock to be purchased
by the Series B Investors and/or the Series A Investors shall be completed
within thirty (30) days of the expiration of the last applicable notice period
set forth in Sections 4(a) or (b), as applicable.

                           (ii) Unless the Series B Investors or the Series A
Investors shall have purchased all of the Offered Stock pursuant to Sections
4(a) or (b), as applicable, the Other Stockholder may sell the Offered Stock to
a Third Party Purchaser on the terms and subject to the conditions set forth in
the Notice; provided, however, that such sale is bona fide and made pursuant to
a contract entered into within sixty (60) days of the earliest to occur of (A)
the waiver by the Series B Investors and the Series A Investors of their options
to purchase the Offered Stock or (B) the expiration of the Series A Notice
Period or (C) the expiration of the time period set forth in Section 4(c)(i)
without the closing of the purchase of the Offered Stock having taken place due
to failure by the Series B Investors and/or the Series A Investors to close (the
earliest of such dates being referred to herein as the "Contract Date"); and
provided further, that such sale shall not be consummated unless and until all
of the following conditions are met:

                                       7
<PAGE>

                           (a)      The Other Stockholder shall deliver to the
                                    Company a certificate of a Third Party
                                    Purchaser stating that (x) such Third Party
                                    Purchaser is aware of the rights of the
                                    Series B Investors and the Series A
                                    Investors contained in this Section 4 and
                                    (y) prior to the purchase by such Third
                                    Party Purchaser of any of such Offered
                                    Stock, such Third Party Purchaser shall
                                    become a party to this Agreement and agree
                                    to be bound by the terms and conditions
                                    hereof; and

                           (b)      The consummation of such sale to a Third
                                    Party Purchaser shall not be subject to any
                                    conditions (other than necessary filings
                                    under the Hart-Scott-Rodino Antitrust
                                    Improvements Act), except that it may be
                                    conditioned upon the truth as of the closing
                                    of the proposed purchase of customary
                                    representations and warranties and the
                                    delivery of stock certificates and a
                                    customary legal opinion.

                           (iii) If such sale is not consummated within sixty
(60) days of the Contract Date for any reason, then the restrictions provided
for herein shall again become effective, and no Transfer of such Offered Stock
may be made thereafter by the Other Stockholder without again offering the same
to the Series B Investors and the Series A Investors in accordance with this
Section 4.

                  5. Sales by Series A Investors.

                       (a) Series B Right of First Refusal.
                           --------------------------------

                           (i) If a Series A Investor proposes to Transfer any
shares of Preferred Stock, other than pursuant to Section 3(e) or 5(d), then
such Series A Investor shall offer such shares first to the Series B Investors,
by sending written notice (the "Notice") to the Series B Investors, with a copy
to the Company and the other Series A Investors, which shall state (A) the
number of shares proposed to be Transferred (the "Offered Stock"), (B) the
identity of the proposed transferee ("Third Party Purchaser"), (C) the proposed
purchase price per share offered by the Third Party Purchaser (the "Offer
Price"), and (D) the material terms and conditions upon which the proposed
Transfer is to be made. Upon delivery of the Notice, such offer shall be
irrevocable unless and until the rights of first offer provided for herein shall
have been waived or shall have expired.

                                       8
<PAGE>

                           (ii) The Series B Investors may elect, by written
notice to the Series A Investor and the Company delivered within fifteen (15)
days after the giving of the Notice pursuant to Section 5(a)(i) (the "Series B
Notice Period"), to purchase any or all of the Offered Stock at a purchase price
equal to the Offer Price and upon the terms and subject to the conditions set
forth in the Notice (the "Series B Option"). Each Series B Investor shall have
the right to purchase that percentage of the Offered Stock determined by
dividing (A) the total number of shares of Investor Stock then owned by such
Series B Investor by (B) the total number of shares of Investor Stock then owned
by all Series B Investors (in each case, calculated on an as converted to Common
Stock basis). The Company shall, within five (5) days of the expiration of the
Series B Notice Period, provide written notice to the fully participating Series
B Investors indicating the number of shares of Offered Stock not elected to be
purchased by the other Series B Investors (the "Company B Option Notice"). If
any Series B Investor does not fully subscribe for the number of shares of
Offered Stock such Series B Investor is entitled to purchase, then each other
fully participating Series B Investor may elect by written notice delivered to
the Preferred Stockholder and the Company within five (5) days of delivery of
the Company B Option Notice to purchase that percentage of the remaining Offered
Stock not so subscribed for determined by dividing (x) the total number of
shares of Investor Stock then owned by such fully participating Series B
Investor by (y) the total number of shares of Investor Stock then owned by all
fully participating Series B Investors who elected to purchase the remaining
Offered Stock (in each case, on an as converted to Common Stock basis).

                           (iii) The failure of a Series B Investor to respond
within the Series B Notice Period to the Series A Investor and the Company shall
be deemed to be a waiver of such Series B Investor's rights under this Section
5(a), provided that each Series B Investor may waive its rights under this
Section 5(a) prior to the expiration of the Series B Notice Period by giving
written notice to the Series A Investor and the Company.

                       (b) Series A Right of First Refusal.
                           --------------------------------

                           (i) The Company shall within five (5) days of the
expiration of the last applicable time period set forth in Section 5(a)(ii)
above provide notice to the other Series A Investors of the number of shares of
Offered Stock, if any, that the Series B Investors did not elect to purchase.
The other Series A Investors may elect within fifteen (15) days after delivery
of such notice (the "Series A Notice Period") to purchase any or all of the
remaining Offered Stock at a purchase price equal to the Offer Price and upon
the terms and subject to the conditions set forth in the Notice (the "Series A
Option"). Each such Series A Investor shall have the right to purchase that
percentage of the remaining Offered Stock determined by dividing (x) the total
number of shares of Investor Stock then owned by such Series A Investor by (y)
the total number of shares of Investor Stock then owned by all Series A
Investors (in each case, calculated on an as converted to Common Stock basis).
The Company shall, within five (5) days of the expiration of the Series A Notice
Period, provide written notice to the fully participating Series A Investors
indicating the number of shares of Offered Stock not elected to be purchased by
the other Series A Investors (the "Company A Option Notice"). If any Series A
Investor does not fully subscribe for the number of shares of Offered Stock such
Series A Investor is entitled to purchase, then each other fully participating
Series A Investor may elect by written notice delivered to the transferring
Series A Investor and the Company within five (5) days of delivery of the
Company A Option Notice to purchase that percentage of the remaining Offered
Stock not so subscribed for determined by dividing (I) the total number of
shares of Investor Stock then owned by such fully participating Series A
Investor by (II) the total number of shares of Investor Stock then owned by all
fully participating Series A Investors who elected to purchase the remaining
Offered Stock (in each case, calculated on an as converted to Common Stock
basis).

                                       9
<PAGE>

                           (ii) The failure of a Series A Investor to respond
within the Series A Notice Period to the transferring Series A Investor and the
Company shall be deemed to be a waiver of such Series A Investor's rights under
this Section 5(b), provided that each Series A Investor may waive its rights
under this Section 5(b) prior to the expiration of the Series A Notice Period by
giving written notice to the transferring Series A Investor and the Company.

                       (c) Settlement.
                           -----------

                           (i) The Closing of the Offered Stock to be purchased
by the Series B Investors and/or the non-transferring Series A Investors shall
be completed within thirty (30) days of the expiration of the last applicable
notice period set forth in Sections 5(a) or (b), as applicable.

                           (ii) Unless the Series B Investors or the Series A
Investors shall have purchased all of the Offered Stock pursuant to Sections
5(a) or (b), as applicable, the transferring Series A Investor may, subject to
Section 5(d), sell the Offered Stock to a Third Party Purchaser on the terms and
subject to the conditions set forth in the Notice; provided, however, that such
sale is bona fide and made pursuant to a contract entered into within sixty (60)
days of the earliest to occur of (A) the waiver by the Series B Investors and
the Series A Investors of their options to purchase the Offered Stock or (B) the
expiration of the Series A Notice Period or (C) the expiration of the time
period set forth in Section 5(c)(i) without the closing of the purchase of the
Offered Stock having taken place due to failure by the Series B Investors and/or
Series A Investors to close (the earliest of such dates being referred to herein
as the "Contract Date"); and provided further, that such sale shall not be
consummated unless and until all of the following conditions are met:

                           (a)      The transferring Series A Investor shall
                                    deliver to the Company a certificate of a
                                    Third Party Purchaser stating that (x) such
                                    Third Party Purchaser is aware of the rights
                                    of the Series B Investors and the Series A
                                    Investors contained in this Section 5 and
                                    (y) prior to the purchase by such Third
                                    Party Purchaser of any of such Offered
                                    Stock, such Third Party Purchaser shall
                                    become a party to this Agreement and agree
                                    to be bound by the terms and conditions
                                    hereof; and

                           (b)      The consummation of such sale to a Third
                                    Party Purchaser shall not be subject to any
                                    conditions (other than necessary filings
                                    under the Hart-Scott-Rodino Antitrust
                                    Improvements Act), except that it may be
                                    conditioned upon the truth as of the closing
                                    of the proposed purchase of customary
                                    representations and warranties and the
                                    delivery of stock certificates and a
                                    customary legal opinion.

                           (iii) If such sale is not consummated within sixty
(60) days of the Contract Date for any reason, then the restrictions provided
for herein shall again become effective, and no Transfer of such Offered Stock
may be made thereafter by the transferring Series A Investor without again
offering the same to Series B Investors and the other Series A Investors in
accordance with this Section 5.

                                       10
<PAGE>

                       (d) Co-Sale Right.
                           --------------

                           (i) If a Series A Investor is Transferring stock to a
Third Party Purchaser pursuant to Section 5(c)(ii), then each Series A Investor
that has not exercised the Series A Option (other than the transferring Series A
Investor) shall have the right, exercisable upon written notice to such
transferring Series A Investor within thirty (30) days after receipt of the
Notice, to participate in such sale of Investor Stock on the same terms and
conditions. To the extent one or more of the Series A Investors exercise such
right of participation in accordance with the terms and conditions set forth
below, the number of shares of Investor Stock that the transferring Series A
Investor may sell in the transaction shall be correspondingly reduced.

                           (ii) Each non-transferring Series A Investor may sell
all or any part of that number of shares of Investor Stock equal to the product
obtained by multiplying (A) the aggregate number of shares of Investor Stock
covered by the Notice by (B) a fraction, the numerator of which is the number of
shares of Investor Stock owned by the non-transferring Series A Investor at the
time of the Transfer and the denominator of which is the total number of shares
of Investor Stock owned by all the Series A Investors (other than the
transferring Series A Investor) at the time of the Transfer (in each case,
calculated on an as converted to Common Stock basis).

                           (iii) If any Series A Investor fails to elect to
fully participate in such transferring Series A Investor's sale pursuant to this
Section 5(d), the transferring Series A Investor shall give notice of such
failure to the Series A Investors who did so elect (the "Participants"). The
Participants shall have five days from the date such notice was given to agree
to sell their pro rata share of the unsold portion. For purposes of this
paragraph, a Participant's pro rata share shall be the ratio of (x) the number
of shares of Investor Stock held by such Participant to (y) the total number of
shares of Investor Stock held by all the Participants (in each case, calculated
on an as converted to Common Stock basis).

                           (iv) The exercise or non-exercise of the rights of
the Participants hereunder to participate in one or more sales of Investor Stock
made by the transferring Series A Investor shall not adversely affect their
rights to participate in subsequent sales of Investor Stock subject to this
Section 5.

                           (v) In the event the transferring Series A Investor
has not sold the Investor Stock subject to the aforementioned provisions within
the time period specified in Section 5(c)(i), the transferring Series A Investor
shall not thereafter sell any Investor Stock subject to the provisions of this
agreement without again being subject to the rights of the Preferred
Stockholders as here prescribed.

                                       11
<PAGE>

                  6. Sales by Series B Investors.

                       (a) Series B Right of First Refusal.
                           --------------------------------

                           (i) If a Series B Investor proposes to Transfer any
shares of Preferred Stock, other than pursuant to Section 3(e), 5(d) or 6(c),
then such Series B Investor shall offer such shares first to the other Series B
Investors, by sending written notice (the "Notice") to the other Series B
Investors, with a copy to the Company, which shall state (A) the number of
shares proposed to be Transferred (the "Offered Stock"), (B) the identity of the
proposed transferee ("Third Party Purchaser"), (C) the proposed purchase price
per share offered by the Third Party Purchaser (the "Offer Price"), and (D) the
material terms and conditions upon which the proposed Transfer is to be made.
Upon delivery of the Notice, such offer shall be irrevocable unless and until
the rights of first offer provided for herein shall have been waived or shall
have expired.

                           (ii) The other Series B Investors may elect, by
written notice to the transferring Series B Investor and the Company delivered
within fifteen (15) days after the giving of the Notice pursuant to Section
6(a)(i) (the "Series B Notice Period"), to purchase any or all of the Offered
Stock at a purchase price equal to the Offer Price and upon the terms and
subject to the conditions set forth in the Notice (the "Series B Option"). Each
non-transferring Series B Investor shall have the right to purchase that
percentage of the Offered Stock determined by dividing (A) the total number of
shares of Investor Stock then owned by such Series B Investor by (B) the total
number of shares of Investor Stock then owned by all Series B Investors (in each
case, calculated on an as converted to Common Stock basis). The Company shall,
within five (5) days of the expiration of the Series B Notice Period, provide
written notice to the fully participating Series B Investors indicating the
number of shares of Offered Stock not elected to be purchased by the other
Series B Investors (the "Company B Option Notice"). If any Series B Investor
does not fully subscribe for the number of shares of Offered Stock such Series B
Investor is entitled to purchase, then each other fully participating Series B
Investor may elect by written notice delivered to the transferring Series B
Investor and the Company within five (5) days of delivery of the Company B
Option Notice to purchase that percentage of the remaining Offered Stock not so
subscribed for determined by dividing (x) the total number of shares of Investor
Stock then owned by such fully participating Series B Investor by (y) the total
number of shares of Investor Stock then owned by all fully participating Series
B Investors who elected to purchase the remaining Offered Stock (in each case,
on an as converted to Common Stock basis).

                           (iii) The failure of a Series B Investor to respond
within the Series B Notice Period to the transferring Series B Investor and the
Company shall be deemed to be a waiver of such Series B Investor's rights under
this Section 6(a), provided that each Series B Investor may waive its rights
under this Section 6(a) prior to the expiration of the Series B Notice Period by
giving written notice to the transferring Series B Investor and the Company.

                       (b) Settlement.
                           -----------

                           (i) The Closing of the Offered Stock to be purchased
by the non-transferring Series B Investors shall be completed within thirty (30)
days of the expiration of the last applicable notice period set forth in
Sections 6(a).

                                       12
<PAGE>

                           (ii) Unless the non-transferring Series B Investors
shall have purchased all of the Offered Stock pursuant to Sections 6(a), the
transferring Series B Investor may, subject to Section 6(c), sell the Offered
Stock to a Third Party Purchaser on the terms and subject to the conditions set
forth in the Notice; provided, however, that such sale is bona fide and made
pursuant to a contract entered into within sixty (60) days of the earliest to
occur of (A) the waiver by the non-transferring Series B Investors of their
options to purchase the Offered Stock or (B) the expiration of the Series B
Notice Period or (C) the expiration of the time period set forth in Section
6(b)(i) without the closing of the purchase of the Offered Stock having taken
place due to failure by the Series B Investors to close (the earliest of such
dates being referred to herein as the "Contract Date"); and provided further,
that such sale shall not be consummated unless and until all of the following
conditions are met:

                           (a)      The transferring Series B Investor shall
                                    deliver to the Company a certificate of a
                                    Third Party Purchaser stating that (x) such
                                    Third Party Purchaser is aware of the rights
                                    of the Series B Investors contained in this
                                    Section 6 and (y) prior to the purchase by
                                    such Third Party Purchaser of any of such
                                    Offered Stock, such Third Party Purchaser
                                    shall become a party to this Agreement and
                                    agree to be bound by the terms and
                                    conditions hereof; and

                           (b)      The consummation of such sale to a Third
                                    Party Purchaser shall not be subject to any
                                    conditions (other than necessary filings
                                    under the Hart-Scott-Rodino Antitrust
                                    Improvements Act), except that it may be
                                    conditioned upon the truth as of the closing
                                    of the proposed purchase of customary
                                    representations and warranties and the
                                    delivery of stock certificates and a
                                    customary legal opinion.

                           (iii) If such sale is not consummated within sixty
(60) days of the Contract Date for any reason, then the restrictions provided
for herein shall again become effective, and no Transfer of such Offered Stock
may be made thereafter by the transferring Series B Investor without again
offering the same to the other Series B Investors in accordance with this
Section 6.

                       (c) Co-Sale Right.
                           --------------

                           (i) If a Series B Investor is Transferring stock to a
Third Party Purchaser pursuant to Section 6(b)(ii), then each Series B Investor
that has not exercised the Series B Option (other than the transferring Series B
Investor) shall have the right, exercisable upon written notice to such
transferring Series B Investor within thirty (30) days after receipt of the
Notice, to participate in such sale of Investor Stock on the same terms and
conditions. To the extent one or more of the Series B Investors exercise such
right of participation in accordance with the terms and conditions set forth
below, the number of shares of Investor Stock that the transferring Series B
Investor may sell in the transaction shall be correspondingly reduced.

                           (ii) Each non-transferring Series B Investor may sell
all or any part of that number of shares of Investor Stock equal to the product
obtained by multiplying (A) the aggregate number of shares of Investor Stock
covered by the Notice by (B) a fraction, the numerator of which is the number of
shares of Investor Stock owned by the non-transferring Series B Investor at the
time of the Transfer and the denominator of which is the total number of shares
of Investor Stock owned by all the Series B Investors (other than the
transferring Series B Investor) at the time of the Transfer (in each case,
calculated on an as converted to Common Stock basis).

                                       13
<PAGE>

                           (iii) If any Series B Investor fails to elect to
fully participate in such transferring Series B Investor's sale pursuant to this
Section 6(c), the transferring Series B Investor shall give notice of such
failure to the Series B Investors who did so elect (the "Participants"). The
Participants shall have five days from the date such notice was given to agree
to sell their pro rata share of the unsold portion. For purposes of this
paragraph, a Participant's pro rata share shall be the ratio of (x) the number
of shares of Investor Stock held by such Participant to (y) the total number of
shares of Investor Stock held by all the Participants (in each case, calculated
on an as converted to Common Stock basis).

                           (iv) The exercise or non-exercise of the rights of
the Participants hereunder to participate in one or more sales of Investor Stock
made by the transferring Series B Investor shall not adversely affect their
rights to participate in subsequent sales of Investor Stock subject to this
Section 6.

                           (v) In the event the transferring Series B Investor
has not sold the Investor Stock subject to the aforementioned provisions within
the time period specified in Section 6(b)(i), the transferring Series B Investor
shall not thereafter sell any Investor Stock subject to the provisions of this
agreement without again being subject to the rights of the Series B Investors as
here prescribed.

                  7. Non-Cash Purchase Price. Notwithstanding anything in
Sections 3(b), 3(c), 4(a), 4(b), 5(a), 5(b) or 6(a) to the contrary, should the
purchase price specified in the applicable Notice be payable in property other
than cash or evidences of indebtedness, the Series B Investors and/or the Series
A Investors, as the case may be, shall have the right to pay the purchase price
in the form of cash equal in amount to the fair market value of such property.
If the transferring Stockholder and the Stockholders exercising a right of first
refusal hereunder cannot agree on such fair market value within five (5) days
after the non-transferring Stockholder's receipt of the Notice, the valuation
shall be made by an appraiser of recognized standing selected by the
transferring Stockholder and the Stockholders exercising a right of first
refusal hereunder or, if they cannot agree on an appraiser within ten (10) days
after such receipt of the Notice, each shall select an appraiser of recognized
standing and the two appraisers shall designate a third appraiser of recognized
standing, whose appraisal shall be determinative of such value. The cost of such
appraisal shall be shared equally by the transferring Stockholder and the
exercising Stockholders, with the half of the cost borne by exercising
Stockholders borne pro rata by each based on the number of shares such parties
were interested in purchasing pursuant to the applicable right of first refusal.
If the time for the closing of the exercising Stockholders' purchase has expired
but for the determination of the value of the purchase price offered by the
prospective transferee(s), then such closing shall be held on or prior to the
fifth (5th) business day after such valuation shall have been made pursuant to
this subsection.

                                       14
<PAGE>

                  8. Exempt Transfers. Notwithstanding the foregoing, the rights
of the Preferred Stockholders and the Company shall not apply to any Transfer
(i) to the Company, (ii) by a Series B Investor to another Series B Investor or
an investor in such Series B Investor, (iii) by a Founder, an Other Stockholder
or a Preferred Stockholder to the ancestors, descendants or spouse or to trusts
for the benefit of such persons or such Founder, Other Stockholder or Preferred
Stockholder or a charitable remainder trust or (iv) by a Preferred Stockholder
to an affiliate of such Preferred Stockholder; provided in each case that (x)
the transferring Founder, Other Stockholder or Preferred Stockholder shall
inform all the Preferred Stockholders and the Company of the Transfer prior to
effecting it and (y) the Transferee shall furnish the parties hereto with a
written agreement to be bound by and comply with all provisions of this
Agreement (collectively, the "Permitted Transferees"). Such transferred Founder
Stock, Common Stock or Investor Stock shall remain "Founder Stock," "Common
Stock" or "Investor Stock" hereunder, as applicable, and such Permitted
Transferee shall be treated as a "Founder," "Other Stockholder" or "Preferred
Stockholder," as applicable, for purposes of this Agreement.

                  9. Legend.

                       (a) Each certificate representing shares of Founder
Stock, Common Stock or Investor Stock now or hereafter owned by a Founder, Other
Stockholder or Preferred Stockholder or issued to any person in connection with
a transfer pursuant to Section 8 hereof shall be endorsed with the following
legend:

                  "THE SALE, PLEDGE, HYPOTHECATION OR TRANSFER OF THE
         SECURITIES REPRESENTED BY THIS CERTIFICATE IS SUBJECT TO THE
         TERMS AND CONDITIONS OF A CERTAIN STOCKHOLDERS' AGREEMENT BY
         AND AMONG THE CORPORATION AND THE STOCKHOLDERS OF THE
         CORPORATION. COPIES OF SUCH AGREEMENT MAY BE OBTAINED UPON
         WRITTEN REQUEST TO THE SECRETARY OF THE CORPORATION."

                       (b) Each of the Founders, the Other Stockholders and the
Preferred Stockholders agrees that the Company may instruct its transfer agent
to impose transfer restrictions on the shares represented by certificates
bearing the legend referred to in Section 9(a) above to enforce the provisions
of this Agreement and the Company agrees to promptly do so. The legend shall be
removed upon termination of this Agreement.

                  10. Bring-Along Right. In the event that Stockholders (the
"Proposing Stockholders") holding stock comprising at least seventy-five percent
(75%) of the Company's voting securities (the "Threshold Percent") propose to
Transfer their stock to a third party (the "Offeror") pursuant to a merger,
consolidation, reorganization or sale of shares, the remaining Stockholders will
be required to sell their stock to such Offeror at the same price and upon the
same terms and conditions as in the offer made to the Proposing Stockholders or
vote in favor of the transaction, in the case of a merger, consolidation or
reorganization; provided, however, that the Series B Investors shall not be
required to sell their shares or vote in favor of the transaction, as
applicable, unless such transaction reflects a pre-money valuation of at least
$80,000,000.

                                       15
<PAGE>

                  11. Board of Directors.

                       (a) The Board of Directors of the Company shall be
comprised of five directors.

                       (b) For so long as the Founder Stock constitutes at least
seven percent (7%) of the outstanding capital stock of the Company and each of
Shay Ben Asulin and Mati Broudo remains an employee of the Company, the holders
of a majority of the Founder Stock then outstanding, voting as a class, shall
have the right to designate two (2) directors (the "Founder Directors") and, in
any election of directors of the Company, each of the Founders shall vote at any
regular or special meeting of stockholders (or by written consent) such number
of shares of Founder Stock then owned by such Founder (or as to which such
Founder then has voting power) as may be necessary to elect two (2) directors
designated by the Founders. Initially, the directors designated by the Founders
shall be Shay Ben Asulin and Mordecai Brudo. If the holders of a majority of the
Founder Stock then outstanding no longer have the right to designate Founder
Directors pursuant to this Section 11(b), the two (2) directors previously
designated by the Founders shall be nominated and elected by the holders of a
majority of the Common Stock (including shares of Common Stock issued or
issuable upon conversion of the Preferred Stock, on an as converted basis).

                       (c) For so long as the Series A Investors shall be
permitted to designate board seats pursuant to the Restated Articles, in any
election of directors of the Company, each of the Series A Investors shall vote
at any regular or special meeting of stockholders (or by written consent) such
number of shares of Series A Preferred Stock then owned by such Series A
Investor (or as to which such Series A Investor then has voting power) as may be
necessary to elect one (1) director designated by the Series A Investors.
Initially, the director designated by the Series A Investors shall be Dr.
Michael Anghel.

                       (d) For so long as the Series B Investors shall be
permitted to designate board seats pursuant to the Restated Articles, in any
election of directors of the Company, each of the e-street international ag or
any affiliate thereof ("e-street") and D.E.P. Technology Holdings Ltd. or any
affiliate thereof ("DEP") shall vote at any regular or special meeting of
stockholders (or by written consent) such number of shares of Series B Preferred
Stock then owned by such Series B Investor (or as to which such Series B
Investor then has voting power) as may be necessary to elect two (2) directors,
one (1) designated by e-street and one (1) designated by DEP. Initially, the
director designated by DEP shall be Elon Shalev and the director designated by
e-street shall be Amedeo Carassai.

                       (e) Any director of the Company may be removed from the
Board of Directors in the manner allowed by law and the Company's Amended and
Restated Certificate of Incorporation and By-laws, and with respect to a
director designated pursuant to Section 11(a), only upon the vote or written
consent of the parties entitled to designate such director.

                                       16
<PAGE>

                  12. Miscellaneous.

                       (a) Governing Law. This Agreement and all acts and
transactions pursuant hereto shall be governed, construed and interpreted in
accordance with the laws of the State of New York, without giving effect to
principles of conflicts of laws.

                       (b) Amendment. Any term of this Agreement may be amended
or waived only by the written consent of (i) as to the Company, only by the
Company, (ii) as to the Preferred Stockholders, by holders of more than fifty
percent (50%) in interest of the Series A Preferred Stock, e-street and DEP,
provided that any Preferred Stockholder may waive any of his rights hereunder
without obtaining the consent of any other Preferred Stockholder and provided,
further, that in the case of any provision pertaining only to the Series A
Investors, such provision may be waived by the written consent of holders of
more than fifty percent (50%) in interest of the Series A Preferred Stock and in
the case of any provision pertaining only to the Series B Investors, such
provision may be waived by the written consent of each of e-street and DEP,
(iii) as to the Founders, by holders of more than ninety-five percent (95%) in
interest of the Founder Stock and (iv) as to the Other Stockholders, by holders
of more than fifty percent (50%) in interest of the Common Stock (excluding the
Founder Stock). Any amendment or waiver effected in accordance with clauses (i),
(ii), (iii) and (iv) of this paragraph shall be binding upon each Preferred
Stockholder, the Company, the Other Stockholders and the Founders and their
respective successors and assigns.

                       (c) Assignment of Rights. Except as otherwise provided in
this Agreement, the terms and conditions of this Agreement shall inure to the
benefit of and be binding upon the respective successors (including successors
by merger) and permitted assigns of the parties (including transferees of any of
the Founder Stock, Common Stock, Series A Preferred Stock, Series B Preferred
Stock or warrants to purchase shares of Series B Preferred Stock or any Series B
Preferred Stock or Common Stock issued upon conversion or exercise thereof).
Nothing in this Agreement, express or implied, is intended to confer upon any
party other than the parties hereto or their respective successors and assigns
any rights, remedies, obligations, or liabilities under or by reason of this
Agreement, except as expressly provided in this Agreement.

                       (d) Term. This Agreement shall terminate upon the closing
of a firm commitment underwritten public offering by the Company of shares of
its Common Stock pursuant to a registration statement filed in the United States
under the Securities Act of 1933, as amended, or a public offering effected on
the London Stock Exchange, the Frankfurt Stock Exchange or the Paris Stock
Exchange under applicable securities laws which results in aggregate cash
proceeds to the Company of an amount equal to or greater than $20,000,000, net
of underwriting discounts and commissions and a reflecting a pre-offering
valuation of the Company of at least $60,000,000.

                       (e) Notices. All notices required or permitted hereunder
shall be in writing and shall be deemed effectively given: (a) upon personal
delivery to the party to be notified; (b) when sent by confirmed telex or
facsimile if sent during normal business hours of the recipient, if not, then on
the next business day; (c) five (5) days after having been sent by registered or
certified mail, return receipt requested, postage prepaid; or (d) one (1) day
after deposit with a nationally recognized overnight courier, specifying next
day delivery, with written verification of receipt. All communications shall be
sent to the address as set forth on the signature pages hereto or at such other
address as such party may designate by ten (10) days advance written notice to
the other parties hereto.

                                       17
<PAGE>

                       (f) Effect of Change in Company's Capital Structure.
Appropriate adjustments shall be made in the number and class of shares subject
to any provisions of this Agreement in the event of a stock dividend, stock
split, reverse stock split, combination, reclassification or like change in the
capital structure of the Company.

                       (g) Severability. If one or more provisions of this
Agreement are held to be unenforceable under applicable law, the parties agree
to renegotiate such provision in good faith. In the event that the parties
cannot reach a mutually agreeable and enforceable replacement for such
provision, then (a) such provision shall be excluded from this Agreement, (b)
the balance of the Agreement shall be interpreted as if such provision were so
excluded and (c) the balance of the Agreement shall be enforceable in accordance
with its terms.

                       (h) Attorney Fees. In the event that any dispute among
the parties to this Agreement should result in litigation, the prevailing party
in such dispute shall be entitled to recover from the losing party all fees,
costs and expenses of enforcing any right of such prevailing party under or with
respect to this Agreement, including without limitation, such reasonable fees
and expenses of attorneys and accountants, which shall include, without
limitation, all fees, costs and expenses of appeals.

                       (i) Counterparts. This Agreement may be executed in two
or more counterparts, each of which shall be deemed an original, but all of
which together shall constitute one and the same instrument.

                       (j) Titles and Subtitles. The titles and subtitles used
in this Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement.

                       (k) Aggregation of Stock. All shares of the Series A
Preferred Stock or Series B Preferred Stock or Founder Stock held or acquired by
(i) affiliated entities or persons or (ii) persons or entities under common
investment management, shall be aggregated together for the purpose of
determining the availability of any rights under this Agreement.

                       (l) Specific Enforcement. It is agreed and understood
that monetary damages would not adequately compensate an injured party for the
breach of this Agreement by any party, that this Agreement shall be specifically
enforceable, and that any breach or threatened breach of this Agreement shall be
the proper subject of a temporary or permanent injunction or restraining order.
Further, each party hereto waives any claim or defense that there is an adequate
remedy at law for such breach or threatened breach.

                       (m) Entire Agreement; Superseding Effect. This Agreement
and the Waiver constitute the entire agreement between and among the parties
hereto pertaining to the subject matter hereof and any other written or oral
agreements between and among the parties hereto pertaining thereto are expressly
cancelled.

                                       18
<PAGE>

                  IN WITNESS WHEREOF, the parties have executed this Agreement
as of the date first above written.

                                                M-WISE, INC.

                                                By: /s/ Shay Ben-Asulin
                                                    ---------------------------
                                                    Name:  Shay Ben-Asulin
                                                    Title:

                                                    Address:

FOUNDERS:

PROTON MARKETING ASSOCIATES LLC

By:  /s/ Mati Brudo
Name:  Mati Brudo
Title:
Address:

PUTCHKON.COM LLC

By: Shay Ben-Asulin
Name:  Shay Ben Asulin
Title:
Address:

CHINESE WHISPERS LLC

By:  /s/ James Crossly
Name: James Crossly
Title:
Address:

<PAGE>

OGEN LLC

By: Nir Frishman
Name:  Nir Frishman
Title:
Address:

By: /s/ Barak Galili
Name:  Barak Galili
Title:
Address:

STOCKHOLDERS:

CAP VENTURES LTD.

By: /s/ Dr. Michael Anghel
Name:  Dr. Michael Anghel
Title:
Address:

E-STREET INTERNATIONAL AG

By:________________________________
Name:
Title:
Address:

D.E.P. TECHNOLOGY HOLDINGS LTD.

By:________________________________
Name:
Title:
Address:

/s/ Doron Cohen
------------------------------------
Doron Cohen

/s/ Irit Cohen
------------------------------------
Irit Cohen

/s/ Yuval Horn
------------------------------------
Yuval Horn

<PAGE>

                                   SCHEDULE A

                               SERIES A INVESTORS

                              Shares of                      Warrants for
Name and Address      Series A Preferred Stock         Series A Preferred Stock
----------------      ------------------------         ------------------------
Cap Ventures Ltd.              268,382                          56,180

<PAGE>

                                   SCHEDULE B

                               SERIES B INVESTORS

<TABLE>
<CAPTION>

                                                                   Series B Preferred
                                        Shares of Series B           Stock Aggregate       Warrant Aggregate
Name                                     Preferred Stock             Purchase Price          Exercise Price
----                                    ------------------         ------------------      ------------------
<S>                                     <C>                        <C>                     <C>
e-street international ag                   244,728                   $2,000,161.94            $1,000,000
D.E.P. Technology Holdings Ltd.             244,728                   $2,000,161.94            $1,000,000

</TABLE>

<PAGE>

                                   SCHEDULE C

                                    FOUNDERS

Name                                     Shares of Common Stock
----                                     ----------------------
Proton Marketing Associates, LLC         332,640
Putchkon.com, LLC                        258,720
Chinese Whispers, LLC                    100,800
Ogen, LLC                                147,840

<PAGE>

                                   SCHEDULE D

                               OTHER STOCKHOLDERS

Name                                Shares of Common Stock
----                                ----------------------
Doron Cohen                         10,695
Irit Cohen                          10,695
Yuval Horn                          15,348

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00057-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00057-of-00352.parquet"}]]